Ayurveda has been found to be effective in maintaining blood sugar levels in Type 2 diabetes patients.

Ayurvedic remedies are in demand as they control blood sugar and limit harmful effects where current drugs have limited efficacy.

A pilot project on Ayurveda treatment for diabetes has been suggested, with treatment camps organized in locations like Mysore.

The WHO has a centre in India that uses AI and big data to set standards for traditional medicine research.

The WHO centre in India, backed by a $250 million grant, acknowledges that 80% of the global population uses traditional medicine.

Ashwagandha, an Indian herb, reduces anxiety, stress, and fatigue, and is being studied as a potential treatment for long Covid symptoms.

A double-blind clinical trial of 2,000 participants is studying Ashwagandha's effectiveness in treating long Covid symptoms over a year.

The Ashwagandha study is funded by India's Ministry of Ayush and supported by the WHO.

The Indian government has established institutions like the All India Institute of Ayurveda to promote traditional Indian medicine.

The WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, aims to leverage traditional Indian practices for global health.

The centre will promote wellness through traditional medicine and evidence-based management of non-communicable diseases.

The Ministry of Ayush has signed a WHO agreement to use AI and big data for setting traditional medicine research standards.

The WHO centre will help countries integrate traditional medicine, used by 80% of the world's population, into their health systems.

The Global Centre for Traditional Medicine will unlock the potential of Ayurveda.

The Sreedhareeyam Ayurvedic Eye Hospital in Kerala restores vision using traditional Indian medicine.

The Ayurvedic hospital in Dudhnoi, Assam, has been inaugurated with Ministry of Ayush support.

The National Ayush Mission supports 33 integrated Ayush hospitals in Northeast India.

IIT Delhi researchers found Yoga and Ayurveda can relieve anxiety in high-risk COVID-19 patients.

More than half of symptomatic patients improved within 5 days of treatment with personalized Ayurvedic medicines and yoga.

Most patients recovered 90% within 10 days, and yoga poses helped those with low oxygen saturation.

A study found 400 medicinal plants with anti-diabetic properties and 21 herbal plants with anti-hyperglycemic action.

The CSIR has developed BGR-34, a herbal formulation that manages diabetes, obesity, and reduces sugar levels.

Ashwagandha reduces anxiety and stress, and improves muscle strength, according to clinical trials.

Herbal eye drops have been found to cure cataract and glaucoma, with 308 patients showing positive results and 91 percent no longer needing spectacles.

The herbal eye drops have no side effects, require no prescription, and restore eyesight in 61 percent of patients.

The Indian government is integrating traditional and modern medicine by operationalizing 12,500 Ayush health centres by 2023-24.

The Ministry of Ayush has released Rs 719.70 crore to southern states under the National Ayush Mission for health promotion and disease management.

The NAM aims to provide Ayush healthcare services nationwide, focusing on outcome-based measurement.

India is promoting Ayurveda and Yoga, having the world's oldest medical systems.

The Jammu and Kashmir government has established a Unani Medical College and Hospital and upgraded 442 AYUSH Dispensaries.

Eleven AYUSH projects, including hospitals and wellness centres, have been approved in J&K.

Dr Abby Philips warns against using Giloy herb due to liver toxicity concerns.

The Kerala State Medical Council sent a notice to Dr Philips for criticizing Giloy, which the AYUSH ministry defended amid toxicity concerns.

The integration of Indian herbal remedies into modern healthcare poses challenges, including regulation and safety, with the WHO emphasizing the need for rigorous standards.

The WHO is guiding policies and standards for safe traditional medicine use.

Only 124 WHO member states regulate herbal medicines, which often lack proven scientific value.

India seeks Ayurveda's inclusion in WHO's ICD-11 list to enhance reporting and enable insurance coverage.

The Ministry of Ayush is supporting regulation and standardization of Ayurveda.

The Indian government has a grievance cell for public complaints, including concerns about herbal remedies.

The Union Health Ministry regulates drug quality in India, including herbal remedies.

The Indian pharmacopeia ensures the safety and efficacy of herbal remedies.

Standards are established for herbal remedy safety and regulators are built up to ensure compliance.

India's regulatory framework bridges traditional and modern medicine for phytopharmaceuticals.

India has the world's oldest medical cannabis regime, with Ayurveda recognizing it as a medicinal plant.

The global medical cannabis industry is expected to hit USD 100 billion by 2028, and Ayurveda records over 200 classical cannabis-based formulations.

Cannabinoid medicine treats chronic conditions like neuropathic pains and is regulated by the Indian drugs regulator.

The WHO has called for strengthened quality control and laws against substandard medicines.

India has allocated $80 million to strengthen drug regulation, with pharmaceutical exports now at $24.5 billion.

The WHO has proposed a global centre for traditional medicine in India to promote global health and wellness.

The centre will use modern science to enhance traditional medicines and wellness practices.

The WHO supports integrating traditional medicine, including herbal remedies like Ashwagandha, into modern healthcare.

The safety and efficacy of Indian herbal remedies are ensured through methods including artificial intelligence, chemical analysis, and spectrometry.

The global herbal medicine market is valued at $150 billion and is projected to reach $230 billion by 2027, led by Asia-Pacific.

The Indian government has set new standards for pharmaceutical manufacturing, requiring ingredient testing before product marketing.

The CDSCO aims to protect public health in India, but enforces Good Manufacturing Practices loosely.

India's drug regulation is governed by the Drugs and Cosmetics Act, 1940, which requires clinical trial data for new drug approvals.

The WHO centre for traditional medicine will help countries integrate traditional medicine into their health systems using AI and big data.

The Indian government has allocated $250 million for the WHO Global Centre for Traditional Medicine.

The centre will use AI and big data to study and standardize traditional medicine.

The WHO recognizes traditional medicine's importance, used by 80% of the world's population, with 40% of approved drugs derived from natural substances.

Ashwagandha has anti-inflammatory properties, reduces anxiety, and improves sleep and mental function.

Ashwagandha treats stress and fatigue by balancing hormones and reducing cortisol levels.

Turmeric helps control blood sugar, limiting the harmful effects of other drugs, making it useful for treating Type 2 diabetes.

Ayurvedic remedies like Turmeric treat diabetes with limited side effects through lifestyle modification and detoxification.

Indian herbal remedies like Ashwagandha and Turmeric modulate the gut microbiome, reduce inflammation, and balance hormones.

The WHO has established a traditional medicine chapter in its ICD-11.

India seeks to include Ayurveda in the WHO's ICD-11 list to link traditional medicine to global norms.

The WHO centre for traditional medicine will promote its safe and effective use to improve global health.

Ayurveda has been found to be effective in maintaining blood sugar levels in Type 2 diabetes patients.

Title:

Content: News

Take up pilot project on Ayurveda treatment: MLA Ramdas

August 29, 2022

Mysore/Mysuru: Studies conducted across the world have found that several traditional medicines commonly used in India as part of Ayurveda are effective in maintaining blood sugar levels in patients with Type 2 diabetes.

Ayurveda is a traditional medical system that has been used for thousands of years in India and some of the herbs included are also used in other parts of the world. In this direction, a systematic project must be developed to treat diabetes, suggested MLA S.A. Ramdas. The suggestion was accepted by Ayurveda practitioners and experts in the field.

The MLA was speaking after inaugurating a free Ayurvedic treatment camp organised at the Sri Ganapathy Ashram on Nanjangud Road yesterday. The camp was organised inside the auditorium of Lakshminarasimha Kuteera of the Ashram by the Government Ayurvedic Research Centre and Ayurveda Academy of Chamarajpet in Bengaluru.

Ramdas suggested the doctors and officers launch a pilot project in a particular locality or a Ward and assured of making all facilities on behalf of the Government. He said that the project can be taken up on Sept. 17, the birthday of Prime Minister Narendra Modi for one year to achieve tangible results for the target population, he suggested.

Modern diabetes drugs are known for side effects and toxicity while Ayurveda works by controlling blood sugar and limiting the harmful effects of other drugs. Turmeric, for example, has been used for the treatment of diabetes in Ayurveda and traditional Chinese medicine, he added.

He said new Ayurvedic remedies were still in great demand for treating diabetes because of the limited efficacy and undesirable side effects of current drugs. A multi-pronged and individualised approach must be used to manage health conditions such as lifestyle modification, Ayurvedic detoxifying and purifying therapies and Ayurvedic medicines containing plant, animal, or mineral-origin ingredients, he added.

University of Mysore Vice-Chancellor Prof. G. Hemantha Kumar, Assistant Director of Government Ayurvedic Research Centre Dr. Lakshminarayana Shenoy, Joint Secretary of Ayurveda Academy Dr. Prashanth Ghokale, Junior pontiff of Ganapathy Ashram Datta Vijayananda Theertha Swamiji and others were present.

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Print Editon: [email protected]
For News/Press Release: [email protected]

In what areas have the medical uses of traditional Indian medicine been studied?

Ayurvedic remedies are in demand as they control blood sugar and limit harmful effects where current drugs have limited efficacy.

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

A pilot project on Ayurveda treatment for diabetes has been suggested, with treatment camps organized in locations like Mysore.

In what areas have the medical uses of traditional Indian medicine been studied?

What is the traditional Indian medical system called?

The WHO has a centre in India that uses AI and big data to set standards for traditional medicine research.

Title:

Content: Archive / Lifestyle
The World Health Organization is interested in alternative medicine.
Mohamed Ismail - Cairo - DPA -
Many people use traditional medicine – but what do these methods really do?
A new WHO centre intends to explore this.
The center is based in India, a country where alternative medicine is so important that it even has its own ministry – which specializes in Ayurveda, Yoga, Physiotherapy, Greek Medicine, Master and Homeopathy.
Indian Prime Minister Narendra Modi attended the opening of the centre in Jamnagar in mid-April, saying: “India ’ s traditional medicine system is not just a cure.
It ’ s a comprehensive science of life. ”
According to the World Health Organization (WHO), the Indian government is supporting the centre with US $250 million (230 million euros).
WHO President Tedros Adhanom Ghebreyesus said: “The center aims to be an engine of innovation, moving towards an agenda of evidence, data and sustainability in traditional medicine, ” adding that the center would connect traditional medicine practitioners around the world and help set standards for research.
Traditional medicine is a broad field.
According to the World Health Organization ’ s statement for the center, 80% of the world ’ s population uses traditional medicine, which includes among other things acupuncture, Ayurvedic medicine and herbal blends.
Traditional medicine is also represented in modern science.
According to the World Health Organization, about 40% of all drugs approved today are derived from natural substances.
The discovery of aspirin, for example, is based on ancient recipes made from the bark of the willow tree.
The research for artemisinin for use in the fight against malaria, for which the Nobel Prize was awarded in 2015, began with the study of ancient texts of Chinese medicine.
George Rochmeyer of Cochrane, an international network that provides the scientific basis for decisions in the health field, said it makes sense at least to take a closer look at treatment methods that have been developed over centuries, to verify the reasonableness of these methods, and to conduct clinical studies on them in case of doubt.
Cochrane reviews are systematic reviews that collect all scientific evidence on a specific issue from medicine or other health sciences.
However, Rochmeyer also stressed that besides the examples of traditional methods cited by the WHO, which form the basis of currently developed treatments, there are likely many other examples where traditional methods of careful review have proven ineffective or even dangerous, such as phlebotomy, noting that spending too much money on studies to review a therapeutic practice is always a matter of discretion.
Rochmeyer stated that there are many Cochrane reviews about the use of traditional methods such as acupuncture in certain cases, but: “From my personal experience at Cochrane, I would say that I have not come across many reviews that have shown really compelling evidence for traditional therapeutic practice. ”
This is often due to the fact that when searching for these treatments we find only a few often-poorly conducted studies that cannot prove or disprove any benefit from them – which brings us back to the question of whether the already limited research funds should be invested in a scientifically unreasonable procedure – for example, homeopathy.
Professor Emeritus Edzard Ernst, a longtime professor of alternative medicine at the University of Exeter, noted that while it was necessary to wait and see who would lead the center and what it would do, the WHO press release was full of exaggerations.
The World Health Organization says it also wants to use new technologies at the new center for the study of traditional medicine — via artificial intelligence and big data, for example.
The center is expected to focus on providing a reliable evidence base for policy and standards of traditional medicine practices and products.
In addition, the center is supposed to help countries integrate these practices into their health systems.
You may also read.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

Establishing rules for the safe, fair, and effective use of traditional medicine

The WHO centre in India, backed by a $250 million grant, acknowledges that 80% of the global population uses traditional medicine.

Ashwagandha, an Indian herb, reduces anxiety, stress, and fatigue, and is being studied as a potential treatment for long Covid symptoms.

Title:

Content: Tuesday 10 August 2021 1:10 pm

Long Covid cure? Researchers to trial traditional Indian herb treatment

The London School of Hygiene & Tropical Medicine will work with the All India Institute of Ayurveda to determine whether a traditional Indian herb can help people recover from long Covid.

Ashwagandha, commonly known as Indian winter cherry, is traditionally used in the Indian Ayurvedic system of medicine to boost energy, reduce stress and strengthen the immune system.

Experts said recent trials had proven the herb’s efficacy in reducing anxiety, stress, improving muscle strength and reducing fatigue symptoms in patients with chronic diseases.

Long Covid patients can suffer from cognitive dysfunction, poor mental health, extreme fatigue and muscle weakness.

It is estimated these symptoms affect 10 to 20 per cent of Covid survivors and can last for one to three months or longer in many cases.

The study, funded by the Ministry of Ayush of the Government of India, will include a double-blind clinical trial involving 2,000 people living in the UK with long Covid.

Half of the trial participants will take 500mg Ashwagandha tablets twice a day for three months, while the other half will be given a placebo.

Researchers will randomly select participants to have a monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events.

The study is expected to last for over a year.

“Ashwagandha has been shown to reduce symptoms of other conditions that are similar to those of long Covid, so we are hopeful that it will be an effective way to combat the condition,” said Sanjay Kinra, professor in clinical epidemiology at the London School of Hygiene & Tropical Medicine.

The research is also supported by the UK’s All-Party Parliamentary Group on Indian Traditional Sciences and the Traditional Complementary and Integrative Medicine Unit at the World Health Organisation (WHO).

Research is the only way to ensure appropriate integration of traditional medicine knowledge into mainstream medical practice,” said technical officer at WHO Geneva, Geetha Krishnan, who helped to facilitate the research project.

Share

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the psychological aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

A double-blind clinical trial of 2,000 participants is studying Ashwagandha's effectiveness in treating long Covid symptoms over a year.

The Ashwagandha study is funded by India's Ministry of Ayush and supported by the WHO.

The Indian government has established institutions like the All India Institute of Ayurveda to promote traditional Indian medicine.

Title:

Content: Three National Ayush institutes inaugurated by Prime Minister Narendra Modi

New Delhi : The nation today got three National Ayush Institutes of eminence in Ayurveda, Homoeopathy and Unani. Prime Minister Shri Narendra Modi today virtually inaugurated All India Institute of Ayurveda in Goa, National Institute of Unani Medicine in Ghaziabad, and National Institute of Homoeopathy at Delhi from Goa.

The Prime Minister was participating in the valedictory ceremony of the 9th World Ayurveda Congress (WAC) at Panjim, Goa. The four days deliberation at 9th WAC provided a global platform for national and global stakeholders, industry leaders, practitioners, traditional healers, educationists, and manufacturers for engaging in intellectual exchange to strengthen the Ayurveda sector.

The valedictory ceremony was attended by Shri P. S Sreedharan Pillai, Governor of Goa, Shri Pramod Sawant, Chief Minister, Goa, Shri Sarbananda Sonowal, Union Cabinet Minister of Ayush and Ports, Shipping & Waterways and Dr. Munjpara Mahendrabhai, Minister of State for Ayush and Women & Child Development. Shripad Yesso Naik, Minister of State for Tourism and Ports, Shipping and Waterways and President, Vijnana Bharati and others were also present.

Addressing the gathering Prime Minister Shri Narendra Modi, said, “We need to continuously work toward the documentation of ‘Data Based Evidence’, we had Ayurveda’s results as well as effects in our favour, but we were lagging behind in terms of evidence. He emphasized that our medical data, research, and journals have to be brought together to verify every claim on modern scientific parameters.”

He added that more than 30 countries have recognized Ayurveda as a traditional medicine system and we have to further promote Ayurveda in every country of the world. PM emphasized that Ayurveda is not just about treatment, it also promotes wellness. The world is now returning to our traditional medicine and Yoga and Ayurveda are the new hope for the world.

On this occasion, Shri Sarbananda Sonowal said, “Ayush Ministry is committed to imparting Ayush health systems into day to day life of the common man by strengthening systems in Health as well as the Education sectors to the people of India. We want Ayush system to become a part of every household not only in India but globally and are trying our best to fulfill dream of Heal in India.”

The Ayush Minister further added, “with the rapid strides in the Ayush sector, in India’s Azadi ka Amrit Kaal, I firmly believe that under the guidance of PM Shri Narendra Modi, it will certainly be ‘Ayush Ka Amrit Kaal’.

Shri Vijay Kumar Saxena, Lt. Governor, Govt of NCT was the chief guest at National Institute of Homoeopathy (NIH), Delhi. It is a first of its kind to be established in Northern India for developing the Homoeopathic system of medicine. General (Retd) V.K. Singh, Union MoS for Road Transport & Highways and Civil aviation was chief guest at National institute of Unani Medicine (NIUM), Ghaziabad.

Prime Minister also visited Arogya Expo held along with 9th WAC and keenly observed and interacted with participants of the Expo.  Various Ayush institutes and research councils, more than 215 companies, leading Ayurveda’s brands, medicine manufacturers and Ayurveda related educational and R&D institutions participated in the Arogya Expo.

The WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, aims to leverage traditional Indian practices for global health.

Title:

Content: For Quick Alerts
ALLOW NOTIFICATIONS
For Daily Alerts

Yoga Uniting World In Pursuit Of Good Health, Wellness, Says Prime Minister Modi

By

Prime Minister Narendra Modi on Saturday said yoga is uniting the world in pursuit of good health and wellness as he lauded the Indian embassy's "great effort" in Doha for holding a yoga session for people of 114 nationalities. In his tweets, Modi also referred to the Ministry of Ayush signing the 'host country agreement' with the World Health Organization for establishing the WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, and said India is honoured to be home to such a state-of-the-art centre.

"This centre will contribute towards making a healthier planet and leveraging our rich traditional practices for global good," he said.

Traditional medicines and wellness practices from India are very popular globally, he noted, adding that the WHO centre will go a long way in enhancing wellness in society.

The World Health Organization had earlier tweeted that it and the Indian government have agreed to establish the WHO Global Centre for Traditional Medicine to maximise the potential of traditional medicines through modern science and technology.

Story first published: Monday, March 28, 2022, 10:30 [IST]
Read more about: yoga wellness

The centre will promote wellness through traditional medicine and evidence-based management of non-communicable diseases.

Title:

Content: For Quick Alerts
ALLOW NOTIFICATIONS
For Daily Alerts

Yoga Uniting World In Pursuit Of Good Health, Wellness, Says Prime Minister Modi

By

Prime Minister Narendra Modi on Saturday said yoga is uniting the world in pursuit of good health and wellness as he lauded the Indian embassy's "great effort" in Doha for holding a yoga session for people of 114 nationalities. In his tweets, Modi also referred to the Ministry of Ayush signing the 'host country agreement' with the World Health Organization for establishing the WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, and said India is honoured to be home to such a state-of-the-art centre.

"This centre will contribute towards making a healthier planet and leveraging our rich traditional practices for global good," he said.

Traditional medicines and wellness practices from India are very popular globally, he noted, adding that the WHO centre will go a long way in enhancing wellness in society.

The World Health Organization had earlier tweeted that it and the Indian government have agreed to establish the WHO Global Centre for Traditional Medicine to maximise the potential of traditional medicines through modern science and technology.

Story first published: Monday, March 28, 2022, 10:30 [IST]
Read more about: yoga wellness

What does traditional Indian medicine generally treat?

The Ministry of Ayush has signed a WHO agreement to use AI and big data for setting traditional medicine research standards.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

Establishing rules for the safe, fair, and effective use of traditional medicine

The WHO centre will help countries integrate traditional medicine, used by 80% of the world's population, into their health systems.

The Global Centre for Traditional Medicine will unlock the potential of Ayurveda.

Title:

Content: Hindustantimes wants to start sending you push notifications. Click allow to subscribe

'Will take Ayurveda to my country, can help millions': Ex Kenya PM's daughter

The comment came in the backdrop of the World Health Organisation launching its Global Centre for Traditional Medicine (GCTM) in Jamnagar in Gujarat a day ago.
Published on Apr 20, 2022 03:16 PM IST
Written by Shubhangi Gupta | Edited by Chandrashekar Srinivasan, New Delhi

Ayurveda, a traditional healing system that has roots in the Indian subcontinent, has now invited praises from the daughter of Raila Odinga, former prime minister of Kenya. Odinga's daughter Rosemary, who regained her eyesight after undergoing Ayurvedic treatment in India in 2019, has said she would take Ayurveda to Kenya as it can help millions of people.

“Earlier I couldn't see, now I can. PM mentioning my treatment shows close relations b/w our countries. I'll take Ayurveda to my country, it can help millions of people,” news agency ANI quoted her as saying on Wednesday.

The comment came in the backdrop of the World Health Organisation launching its Global Centre for Traditional Medicine (GCTM) in Jamnagar in Gujarat a day ago. Dr Tedros Ghebreyesus, Director-General, World Health Organization (WHO) had also attended the ceremony to lay the foundation stone, alongside Prime Minister Narendra Modi. The WHO centre in Gujarat will be aimed at unlocking the potential of Ayurveda by blending ancient practices with modern science. It will be the first and only global outpost centre for traditional medicine across the world.

RELATED STORIES

Raila Odinga had himself praised Ayurveda and spoken about his intentions of taking Ayurveda to his country. In February, he had discussed with PM Modi the opening of a branch of the same hospital -- where his daughter underwent treatment -- in Kenya. "I have suggested to them that they should come and set up a branch in Nairobi, Kenya and I am going to work with them to set up this centre," ANI had quoted Odinga as saying.

Odinga was referring to Sreedhareeyam Ayurvedic Eye Hospital and Research Centre in Kerala.

After being diagnosed with a brain tumour in 2017, Odinga's daughter had undergone surgery in Nairobi. But in the post-operative period, Rosemary had complained of severe loss of eyesight. She travelled to India in 2019 and underwent treatment at Shreedhareeyam Ayurvedic Eye Hospital in Koothattukulam, Kerala which helped her vision to restore.

SHARE THIS ARTICLE ON
Topics
Start 15 Days Free Trial Subscribe Now
This site uses cookies

This site and its partners use technology such as cookies to personalize content and ads and analyse traffic. By using this site you agree to its privacy policy. You can change your mind and revisit your choices at anytime in future.

OPEN APP

The Sreedhareeyam Ayurvedic Eye Hospital in Kerala restores vision using traditional Indian medicine.

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What is the traditional Indian medical system called?

What treatment did Former Kenyan President's daughter Rosemary Odinga get that helped her regain eyesight?

Traditional Indian medicine Ayurvedic treatment.

The Ayurvedic hospital in Dudhnoi, Assam, has been inaugurated with Ministry of Ayush support.

Title:

Content: Guwahati (Assam) [India], November 2 (ANI): Union Minister of Ports, Shipping & Waterways and Ayush, Sarbananda Sonowal inaugurated the 50-bed Ayurvedic hospital at Dudhnoi in the Goalpara district of Assam on Thursday.

The second such hospital to be opened in Assam in less than a month after Majuli - is equipped with all the major facilities including a state-of-the-art laboratory, a Panchakarma centre, an infertility clinic, a yoga unit apart from the OPD and IPD services.

Also Read | Delhi Air Pollution: Hospitals Witness Spike in Emergency Patients As Air Quality Dips in National Capital, Says AIIMS.

Speaking at the occasion, Sonowal said, "It gives me immense pleasure that people of Dudhnoi and its adjoining areas can now avail the wonders of India's rich heritage of Ayurveda. Under the inspiring leadership of Prime Minister Narendra Modi, India has invested to revive the rich heritage of Ayurveda that has been healing humanity for thousands of years. As Assam, along with the rest of the northeast, receives focussed attention to become the engine of growth for India's next economic resurgence, it is important to have a robust healthcare infrastructure, that is modern, inclusive and integrated."

The Ayurvedic Hospital at Dudhnoi will have OPD services like Kaya Chikitsa, PTSR, Samhita and Siddhant, Shalakya as well as IPD services will have Panchakarma Therapy like Snehan, Swedan, Janu Basti, Griba Basti, Sirodhara; Kriya Kalpa therapy like Karna Poran, Karna Dhupan, Anjan, Tarpan, Parishes among others.

Also Read | Madhya Pradesh Assembly Elections 2023: Defying ED Summons, Arvind Kejriwal Takes Part in Election Roadshow in Singrauli.

The hospital is also equipped with a state-of-the-art laboratory, a yoga unit, a pharmacy. In order to make the Dudhnoi campus a major centre of Ayush in the region, further development of USG facilities, X-ray & ECG facility, Operation Theatre, Kharasutra, upgraded Panchakarma, upgraded Laboratory as well and Labour room will be developed.

"Ayurveda has gained worldwide acknowledgement for its role in managing the COVID-19 pandemic. At the world stage, the role of traditional medicine has been highlighted to complement and build a robust healthcare delivery system. At the G20 New Delhi Leaders Declaration, emphasis was laid on recognising the potential role of evidence-based traditional medicine," Sarbananda Sonowal said.

The event was also graced by the Health Minister, Government of Assam, Keshab Mahanta; MP of Lok Sabha for Guwahati, Queen Oja; the Chief Executive Member (CEM), Rabha Hasong Autonomous Council, Tankeswar Rabha among other senior officials of the Ministry of Ayush, Government of Assam as well as district administration of Goalpara.

"I would also like to inform you that as per data received from the state between January and September of 2023, as many as 78,026 people benefitted through the Ayush system of medicine through AHWC. Ayush Ministry has released Rs 121.75 crore of Centre Share till date to Assam for various activities like Ayush Health & Wellness Centres, 50/30/10 bedded Integrated Ayush Hospital, New Educational Institute, Construction of new dispensaries, Ayush Public Health programmes like Ayush Mobile medical unit, Ayurvidya, Supraja, Supply of essential drugs to dispensaries," he added.

The Union Minister has earlier announced four more such integrated hospitals to be set up in Kaliabor, Kokrajhar, Morigaon, and Baksa; along with ONE 30 bedded hospital in Diphu while one 10 bedded hospital in Bajali to be constructed.

"A total of 100 Ayush dispensaries will be set up in all districts of Assam," he said.

The Ministry of Ayush supports the efforts of State/UT Governments for the implementation of different activities as proposed by the States through their respective State Annual Action Plans (SAAPs) through the Centrally Sponsored Scheme (CSS) of the National Ayush Mission (NAM).

The Ministry has been supporting state governments including Assam to set up Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals (DHs), setting up Integrated Ayush hospitals, new Ayush Dispensaries, operationalisation of Ayush Health and wellness Centres by upgrading the existing Ayush Dispensaries and Sub-centres, upgradation of UG & PG Ayush Education Institutes so that the people may able to avail the services from the Ayush healthcare facilities.

The ministry has supported 33 integrated Ayush hospitals in NE, out of which 9 are operational. (ANI)

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)

The National Ayush Mission supports 33 integrated Ayush hospitals in Northeast India.

IIT Delhi researchers found Yoga and Ayurveda can relieve anxiety in high-risk COVID-19 patients.

Title:

Content: Home » News » education-career » Yoga, Ayurveda Could be Effective in Treating High-Risk Covid-19 Cases, Claims IIT-Delhi Research

Yoga, Ayurveda Could be Effective in Treating High-Risk Covid-19 Cases, Claims IIT-Delhi Research

By: Education and Careers Desk

News18.com

Last Updated: September 13, 2022, 16:36 IST

New Delhi, India

The researchers claimed that that high-risk COVID-19 patients undergo severe anxiety, which may further deteriorate their condition (File Photo)

IIT Delhi researchers suggest that in addition to the treatment for COVID-19, Yoga and Ayurveda maybe instrumental in relieving such patients from anxiety and aid in speedy post-treatment recovery

Advertisement

Yoga and Ayurveda maybe effective in the treatment of high-risk cases of COVID-19, suggests a research study by IIT Delhi on successful treatment of 30 high-risk COVID-19 patients. This study was conducted by a team of researchers at IIT Delhi and Dev Sanskriti Vishwavidyalaya, Haridwar.

The researchers claimed that that high-risk COVID-19 patients undergo severe anxiety, which may further deteriorate their condition. They further suggest that in addition to the treatment for COVID-19, Yoga and Ayurveda maybe instrumental in relieving such patients from anxiety and aid in speedy post-treatment recovery.

Also read| IIT Delhi Launches App to Prevent Bengaluru Floods Like Situation, to Predict Waterlogging

The findings of the study have appeared in the Indian Journal of Traditional Knowledge. The research team consists of Dr Sumitra A Bentur, Private practitioner, Greater Noida (West), Uttar Pradesh, Dr Alka Mishra, Dev Sanskriti Vishwavidyalaya, Haridwar, Uttarakhand; Dr Yogish Kumar, Advait Clinic, Delhi, Dr Sonika Thakral, IIT Delhi, Sanjiv, IIT Delhi and Shaheed Sukhdev College of Business Studies, University of Delhi, Prof Rahul Garg, IIT Delhi.

RELATED NEWS

As per the institute, the patients were prescribed Ayurvedic medicines through telemedicine, and administered a personalized therapeutic yoga programme using video conferencing. Almost all the patients were classified as high-risk owing to one or more of co-morbidities such as diabetes mellitus, hypertension, chronic kidney disease, coronary artery disease (which are known to lead to severe outcomes in cases of COVID-19), and/or age above 60, said IIT Delhi.

“The treatment given to the patients was personalized (in accordance with the classical texts) and took account of each patient’s medical history and the symptoms presented, which made it more effective as compared to a fixed standardized treatment plan," said the IIT.

The treatment included ayurvedic medicines, daily yoga-sessions including deep relaxation techniques, pranayama and basic asanas and some lifestyle modifications. Based on the administered treatment, the cases were categorized into YAS (Yoga-Ayurveda based treatment, with possibly allopathic supplements: 4 patients), YASP (Yoga-Ayurveda based treatment, with possibly allopathic supplements and paracetamol: 6 patients), YAM (Yoga-Ayurveda based treatment, and Modern Western Medicine (MWM), that is, allopathy as adjunct: 6 patients), MYA (first tried MWM, later switched to Yoga-Ayurveda: 14 patients). added the institute.

The patients, most of whom presented with many symptoms prior to the yoga and Ayurveda treatment, were followed-up telephonically regularly until recovery. More than half of symptomatic patients started improving within 5 days (90 per cent within 9 days), more than 60 per cent reported at least 90 per cent recovery within 10 days, added IIT Delhi.

Six patients with oxygen saturation (SpO2) below 95 per cent, benefited through Makarasana and Shithilasana; none progressed to composite endpoints (consisting of admission to Intensive Care Unit, invasive ventilation or death). Considering that approximately 19.3 per cent of the patients with these comorbidities progress to composite end points, the p-value was found to be 7.21 x 10−3.

“The study also demonstrates an urgent need to scientifically examine the Traditional Indian Knowledge systems at the top academic institutions. A timely and suitably designed randomized controlled trial evaluating the efficacy of Ayurveda and Yoga based personalized integrative treatment for COVID-19 would have equipped the people with much more credible and dependable information about their use in managing COVID-19" said Prof Rahul Garg, IIT Delhi, who conceptualized the project.

“Most patients reported that the therapy had a profound impact on their recovery process, with many experiencing improvements with respect to their comorbidities too. By the end of the treatment, several patients had decided to adopt Yoga in their lifestyle, and several turned to the Ayurveda doctors in the team for management/treatment of their comorbidities", said Dr Sonika Thakral who coordinated with the patients for routine follow-up.

“On the whole, the belief of the patients in the efficacy of these traditional systems of medicine was extremely enhanced," said Dr Alka Mishra who administered Ayurveda treatment to some patients. “We are observing an increasing trend towards ancient systems of medicine", said Dr Yogesh Kumar who also administered Ayurveda treatment to some patients.

“The said interventions are believed to have collectively accelerated the recovery process by checking anxiety, instilling peace of mind and enhancing the overall well-being of the patients," said Dr Sumitra A Bentur, private practitioner, who designed the Yoga intervention and conducted Yoga sessions for some of the patients.

Read all the Latest Education News and Breaking News here

Follow us on

About the Author

Education and Careers DeskA team of reporters, writers and editors brings you news, analyses and informati...Read More

first published: September 13, 2022, 16:30 IST
last updated: September 13, 2022, 16:36 IST

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the psychological aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

More than half of symptomatic patients improved within 5 days of treatment with personalized Ayurvedic medicines and yoga.

Most patients recovered 90% within 10 days, and yoga poses helped those with low oxygen saturation.

A study found 400 medicinal plants with anti-diabetic properties and 21 herbal plants with anti-hyperglycemic action.

Title:

Content: Nation

Researchers claim 400 medicinal plants have anti-diabetic properties

X

New Delhi: As a part of its initiatives to reduce the diabetic burden, the scientists have emphasised on exploring the anti-diabetic properties of around 400 medicinal plants to be used in making medicines based on ayurvedic formulations to control type-2 diabetes by reducing sugar level in blood.

According to the researchers from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry and All India Institute of Medical Sciences, Kalyani, as of now, there are 21 herbal plants, including Vijayasar, Jamun, Cumin, Daruharidra, little gourd, bael, fenugreek, neem, amla, turmeric that have been found to have prominent anti-hyperglycemic action.

Stressing that diabetes cure lies in the nature, the researchers asserted that intensive studies have been done on 21 herbs and in-depth research on at least 400 herbal plants is needed to exhibit their anti-diabetic properties..

As per their research paper, which is published in the World Journal of Diabetes, these medicinal plants have been the basis of many drugs to manage diabetes. The researchers have also cited the example of BGR-34, a herbal formulation developed by the

Council of Scientific and Industrial Research (CSIR), which has been used to manage diabetes.

The herbal drug BGR-34 contains not one, but many active compounds derived from four medicinal herbs daruharidra, gudmar, methi and vijayasar. Apart from this, giloe and majeeth have also been added to increase immunity as well as antioxidants levels, said Dr Sanchit Sharma, executive director, AIMIL Pharmaceuticals.

The study titled “Treatment on Nature’s lap: Use of Herbal Products in the Management of Hyperglycemia” stated

that although partial research conducted on eight plants, including pomegranate, shilajit, bean, tea, ginkgo biloba, and saffron demonstrate anti-diabetic properties,

it emphasised the need for further trials.

A recent study conducted by AIIMS Delhi revealed that BGR-34, an Ayurvedic medicine, not only helps in reducing sugar levels but also addresses obesity.

The researchers also noted that several allopathic drugs used in diabetes management have their origins in herbal remedies.

For instance, metformin, a widely prescribed medication, is derived from the Galega officinalis plant, which

was historically used to treat diabetes in 19th century Europe.

Next Story

In what areas have the medical uses of traditional Indian medicine been studied?

The CSIR has developed BGR-34, a herbal formulation that manages diabetes, obesity, and reduces sugar levels.

In what areas have the medical uses of traditional Indian medicine been studied?

Ashwagandha reduces anxiety and stress, and improves muscle strength, according to clinical trials.

In what areas have the medical uses of traditional Indian medicine been studied?

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

Herbal eye drops have been found to cure cataract and glaucoma, with 308 patients showing positive results and 91 percent no longer needing spectacles.

Title:

Content: Sign In
  • ENG

Herbal Eye Drops Can Cure Cataract And Glaucoma, Says Dr Mahender Singh Basu

Dr Mahender Singh Basu, Founder of Dr. Basu Eye Hospital speaks on herbal eye drops as an effective cure for many serious eye problems

Written by Kinkini Gupta |Updated : March 24, 2023 1:52 PM IST

A press conference was held on 23rd of March to address the importance of herbal eye drops that have been proven to be able to cure many complicated eye problems. The doctor who was present in person to talk about their research and study was, Dr Mahender Singh Basu, the Founder of Dr. Basu Eye Hospital and the other experts was also present virtually was Prof. Yamini Bhushan Tripathi, Head of Faculty, Faculty of Ayurveda, Banaras Hindu University. Their research on these eye drops has also been published in the International Journal of Pharmaceutical Sciences and Research. Doctor Basu said during his speech at the press conference that these drops have been clinically tested and all of them have showed positive results in patients. These drops were tested on lakhs of Indians and are also available in the market.

Their study on the effectiveness of these eye drops included 308 cataract patients between the year 2017 and 2019. The results of the study were very positive and people showed significant improvement in uncorrected distance visual acuity (UDVA) and uncorrected near visual acuity (UNVA).

Conclusions Of The Study

Patients used the herbal eye drops for about three months after which they showed improvements in their vision. Doctor stated that there was a major improvement in the near-sightedness and far-sightedness of the patients. All of these patients who showed improvements used to were spectacles before but after using the eye drops; they were able to see without them. This constitutes about 91 per cent of the people from two experiment groups. Moreover, among the patients in the third experiment group, 47 per cent of them showed decrease in their glaucoma power and 61 per cent of the patients in the fourth group were able to regain their eyesight to some extent.

Also Read

More News

Doctor Basu Says There Is No Pressure Of Side Effects

When asked about the eye drops, its effectiveness and side effects, Dr, Basu mentioned that these eye drops have been clinically tested and tried and there have not been any side effects and he concluded by saying that these drops do not have side effects that patients need to worry about.

He also said that, these drops can be used without a medical prescription and it can be used by people with a range if eye problems like, cataract, glaucoma, eye itchiness, eye allergies, eye strain due to excessive technology use. These drops are beneficial for complicated and regular eye problems alike.

Total Wellness is now just a click away.

Follow us on

The herbal eye drops have no side effects, require no prescription, and restore eyesight in 61 percent of patients.

The Indian government is integrating traditional and modern medicine by operationalizing 12,500 Ayush health centres by 2023-24.

Title:

Content: you are here: HomeNewsIndia

Govt working towards scientifically integrating traditional and modern medicine: Sonowal

The ministry is working on operationalisation of 12,500 Ayush health and wellness centres through the support of state and Union territory governments under the National Ayush Mission (NAM) by 2023-24, Sonowal said.

September 07, 2023 / 12:48 AM IST

Ayurveda representational image

India's rich heritage of traditional form of medicine has withstood the test of time and the government has been working towards scientifically integrating it with modern medicine, Union Ayush Minister Sarbananda Sonowal said on Wednesday.

The Regional Review meeting of National Ayush Mission was ceremonially inaugurated by him along with his deputy Munjpara Mahendrabhai.

During the meeting, representatives of all participating states and Union territories presented detailed presentations on the state of Ayush and progress of leading Ayush programmes under implementation.

Speaking on the occasion, Sonowal said, "Our rich heritage and potential of traditional form of medicine has withstood the test of time in generations of humanity to live a better, healthier and happier life. We must take full advantage of this generous forms of medicine - be it Ayurveda, Siddha, Unani, Yoga, Naturopathy, Sowa Rigpa, or Homoeopathy."

He also said that under the visionary leadership of Prime Minister Narendra Modi, the government has been working towards scientifically integrating traditional forms of medicine with the modern medicine.

Highlighting the utility of Ayush system of medicine, he further said that it has some robust programmes like Ayurvidya for promotion of healthy lifestyle through Ayush for school children, Supraja for maternal and neonatal intervention, Vayomitra for geriatric issues; prevention and management of Osteoarthritis and other musculo-skeletal disorders, and Ayush mobile medical units.

The ministry is working on operationalisation of 12,500 Ayush health and wellness centres through the support of state and Union territory governments under the National Ayush Mission (NAM) by 2023-24, Sonowal said.

The ministry of Ayush has so far released Rs 719.70 crore to southern states and Union territories - Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu and Telangana - under NAM since 2014-15, he said, adding it has also supported 17 Integrated Ayush hospitals in the southern states and out of that six are operational as reported by them.

Mahendrabhai stressed on the need to emphasise on outcomes as a more meaningful measure of programme value than output.

"We may have to realign our strategies and techniques to plan, execute and report our performance that facilitates measure of outcomes," the minister of state for Ayush said.

NAM is being implemented with the vision and objectives to provide Ayush health care services throughout the country by strengthening and improving facilities, to provide informed choice to the needy public.

PTI
first published: Sep 7, 2023 12:47 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

The Ministry of Ayush has released Rs 719.70 crore to southern states under the National Ayush Mission for health promotion and disease management.

The NAM aims to provide Ayush healthcare services nationwide, focusing on outcome-based measurement.

India is promoting Ayurveda and Yoga, having the world's oldest medical systems.

Title:

Content: J&K Has Been A Major Center Of Indian System Of Medicine Since Ancient Times: LG Sinha

– Lt Governor addresses Consultative meeting of Commission for Indian System of Medicine.
– Reiterates J&K Government's commitment to make the UT a hub of medical and wellness and to contribute to PM Narendra Modi's vision of ‘Heal in India' and ‘Heal by India'.
– With a rich legacy of medicine system, we are committed for investment and innovation in AYUSH and to strengthen traditional system of medicines. It has tremendous growth potential and J&K bestowed with nature's bounty and rich medicinal plants will promote startups and business units in AYUSH: LG.
– LG highlights several milestones achieved in AYUSH sector of J&K UT.
– Ayurvedic Medical College & Hospital at Akhnoor, Unani Medical College & Hospital at Ganderbal and upgradation of 442 AYUSH Dispensaries have been done for well-being of the people: LG.
– Five 50-Bedded Integrated AYUSH Hospitals in Districts of Kulgam, Kathua, Kupwara, Kishtwar and Samba have been approved by Ministry of AYUSH under National AYUSH Mission to strengthen AYUSH secondary healthcare in the UT of J&K: LG.
– In order to promote Medical Tourism in UT, 6 Specialized AYUSH Wellness Centres at famous tourist places-Pahalgam, Gulmarg, Sonamarg, Patnitop, Katra and Golf Course & Srinagar have been approved, out of which three centres have been made operational: LG Sinha.

Srinagar, Jun 2: Lieutenant Governor Manoj Sinha addressed a Consultative meeting on “Ayushman Bharat Digital Mission – Heal in India, Heal by India,” organized by National Commission for Indian System of Medicine (ISM), Ministry of AYUSH, today at University of Kashmir. Addressing the gathering of health professionals and practitioners of ISM from across the country, the Lt Governor reiterated the commitment of the J&K Government to making the UT a hub of medical and wellness tourism and to contribute to Prime Minister Narendra Modi's vision of ‘Heal in India' and ‘Heal by India'.
He said the deliberations during this important meeting will build a solid framework for exchange of ideas to promote ISM and implementation of two important components of Ayushman Bharat Digital Mission – Healthcare Professional Registry and Healthcare Facility Registry in the UT.
“J&K has been a major center of the Indian system of medicine since ancient times and according to Kalhana's Rajtarangini, a well developed Ayurveda hospital was functional those days. Kalhana wrote that J&K had flourishing Ayurvedic drug manufacturing units and Ayurvedic pharmacies,” said the Lt Governor. With such a rich legacy, we are committed for investment and innovation in AYUSH and to strengthen the traditional system of medicines. It has tremendous growth potential and J&K bestowed with nature's bounty and rich medicinal plants will promote startups and business units in AYUSH, he added. He said the world has recognized the Indian System of Medicine as the oldest, effective and scientific health system for prevention and cure. Now the time has come to connect the new generation with this heritage and rich legacy to fulfil the vision of One Earth, One Health, he added. At the consultative meet, the Lt Governor shared the efforts to strengthen the basic health infrastructure, promote medical tourism in the J&K UT and provide the people with access to world class, affordable and quality healthcare services.
Under the guidance of Prime Minister Narendra Modi ji, the Ministry of AYUSH and J&K administration are working together with the vision of ‘One Earth, One Health' to serve the global community through integrated and ancient Indian System of medicine, he said.
Jammu Kashmir is fully prepared to become an important centre of AYUSH and ‘Heal in India' campaign, which will not only promote medical tourism in the Union Territory, but also create immense business and employment opportunities in the healthcare sector, added the Lt Governor. The Lt Governor also highlighted several milestones achieved in the AYUSH sector of J&K UT. Ayurvedic Medical College and Hospital at Akhnoor, Unani Medical College and Hospital at Ganderbal and upgradation of 442 AYUSH Dispensaries have been done for the well-being of the people. Five 50-Bedded Integrated AYUSH Hospitals in Districts of Kulgam, Kathua, Kupwara, Kishtwar and Samba have been approved by Ministry of AYUSH under National AYUSH Mission to strengthen AYUSH secondary healthcare in the UT of J&K, he said.
In order to promote Medical Tourism in UT, 6 Specialized AYUSH Wellness Centres at famous tourist places-Pahalgam, Gulmarg, Sonamarg, Patnitop, Katra and Golf Course Jammu and Srinagar have been approved, out of which three centres have been made operational, he further added. India is home to the world's oldest medical systems. It is not limited to treatment only. It is a science of understanding life and wellbeing in a holistic manner. Through Yoga and Ayush Centres, it is our endeavour to spread the vision and benefits of Ayurveda to all sections of the society, observed the Lt Governor. The Lt Governor also shared valuable suggestions for integrating local health traditions with the mainstream of Ayurveda by promoting People's Science preserved for centuries and transcribing the rich and diverse Indian medicine knowledge in simple language for the new generation. It is also necessary to understand the roots of the traditional system to establish harmony between the Registry of Professionals and the Registry of Facility and all other disciplines of medicine, he added.
Vaidya Jayant Deopujari, Chairman National Commission for Indian System of Medicine and Prof. (Vaidya) Rakesh Sharma, President, Board of Ethics and Registration, also spoke on the occasion and threw light on the key features of the Ayushman Bharat Digital Mission and the aims and objectives of consultative meeting. Prof. Nilofer Khan, Vice Chancellor, Kashmir University; Bhupinder Kumar, Secretary, Health & Medical Department; Ayushi Sudan, State Mission Director, Ayushman Bharat Digital Mission; senior officials from National Health Authority, ISM and UT Administration; HoDs and scores of health professionals and Ayurvedacharya were present.

What is the traditional Indian medical system called?

The Jammu and Kashmir government has established a Unani Medical College and Hospital and upgraded 442 AYUSH Dispensaries.

Eleven AYUSH projects, including hospitals and wellness centres, have been approved in J&K.

Dr Abby Philips warns against using Giloy herb due to liver toxicity concerns.

Title:

Content: Dr Abby Philips who warned against the use of a herb widely used in alternative medicine, has been sent a letter from the Kerala State Medical Council for Indian Systems of Medicine.

Dr Abby Philips / YouTube screenshot
news Controversy Saturday, February 05, 2022 - 13:46

An interview given by a Kerala hepatologist on the ill effects of ingesting a widely used herb Giloy (Tinospora cordifolia) has landed him in trouble, with the Kerala State Medical Council for Indian Systems of Medicine sending him a notice. For the past seven months, Dr Abby Philips has been receiving several letters, with the most recent one from the Council, for an interview he gave to a Malayalam YouTube channel on Herb-Induced Liver Injuries, in June of last year.

In the video, the Aluva based doctor speaks about liver injuries that are specifically caused by consuming unsafe or toxic herbs as treatment. Speaking to TNM, he said that he referred to published evidence regarding all pseudoscientific practices and specifically some herbal drugs which are toxic to the liver. “I specifically spoke about Giloy, which is very liver toxic, based on a paper from Jaslok Hospital and Research Centre, Bombay,” Philips said. He is a faculty of the Asian Pacific Association for the Study of the Liver (APASL), and has authored guidelines and recommendations to specifically treat ‘herbal liver injuries’, specifically on how to treat and diagnose drug induced liver injuries.

Soon after the interview was released, a complaint was filed and the issue was kicked from one department to another. “A complaint was sent to the Prime Minister’s grievance redressal cell, stating that I was denigrating Ayurveda and causing a split in public opinion. This letter was sent to the AYUSH ministry, which forwarded it to the National Medical Commission (NMC),” he said.

The letter, pointing out Philips's statement in the interview, stated that ‘the said derogatory and misleading clause be immediately removed…otherwise the Ministry shall be compelled to initiate defamatory proceedings against the contravening doctor.’ The NMC’s department of Ethics and Medical conduct forwarded it to Kerala's Ayush department saying that some action should be taken. The state Ayush department forwarded it to the Travancore Cochin Medical Council (TCMC) asking to take specific action as needed. “Finally, I got a letter from the Kerala State Medical Council for Indian Systems of Medicine,” he said and added that the ‘funny’ part is that he is not even a part of the said council, but is a member of TCMC in the Modern Medicine division.

Philips said, “They have not identified or informed me about the kind of professional misconduct I am accused of. One cannot defame a ‘system’ or a ‘supposed science’. I have been asked to respond in my personal capacity but there is no mention of a deadline or what the misleading clause is.” He clarified that there is no separate clause under the Medical Code of Ethics for saying alternative medicine is pseudoscience. While the notice mentions a punishment clause, there is no mention of the crime committed. Dr Philips is now planning to reply through a lawyer asking the Council for proof of what his professional misconduct is, according to the Code of Ethics.

“Just this month, our group alone reported 43 Giloy liver injury cases all over India from 13 hospitals, which was also published in the official journal of the American Association of Study of Liver Diseases (AASLD). I am talking with evidence, so how can they say it is demeaning or degrading?” he asked.

Dr Philips said that he did not have a problem with AYUSH being an independent body, but complained there was no regulation. “Ayush is a regulatory body which is supposed to regulate all alternative medicines and their practice in India. But when a study states that a particular herb is potentially toxic, AYUSH should make the public aware of the issue and caution them. Instead, they are defending the concern and further promoting its sale,'' he alleged.

Topic tags,
Become a TNM Member for just Rs 999!
You can also support us with a one-time payment.

The Kerala State Medical Council sent a notice to Dr Philips for criticizing Giloy, which the AYUSH ministry defended amid toxicity concerns.

The integration of Indian herbal remedies into modern healthcare poses challenges, including regulation and safety, with the WHO emphasizing the need for rigorous standards.

Title:

Content: WHO holds first summit on traditional medicine
Cairo - Center Gate Thursday 17 August 2023, 11: 39 am
The World Health Organization (WHO) on Thursday opened its first summit on traditional medicine, amid the United Nations body ’ s stated quest to gather evidence and data to allow the safe use of such treatments.
Traditional medicines are “the first refuge of millions of people around the world, ” the WHO said, with a summit in India bringing together policymakers and academics to“ mobilize political commitment and encourage evidence-based action ” on these treatments.
WHO President Tedros Adhanom Ghebreyesus said: “WHO is working to gather evidence and data to guide policies, standards and norms for the safe, fair and cost-effective use of traditional medicine. ”
The two-day World Health Organization (WHO) World Summit on Traditional Medicine is being held in conjunction with the G20 Health Ministers ’ Meeting in Gandhinagar, India.
The summit is set to be a regular event, following the opening last year of the World Health Organization ’ s World Centre for Traditional Medicine in the Indian state of Gujarat.
Criticism of traditional medicines
While traditional medicines are widely used in some parts of the world, they also face severe criticism.
The United Nations Health Agency defines traditional medicine as the knowledge, skills and practices used over time to maintain health and to prevent, diagnose and treat physical and mental illnesses.
But many traditional treatments lack any proven scientific value, and conservation activists say the industry is pushing for increased trade in endangered animals, including tigers, rhinos and squam-eaters, and threatening the survival of entire species.
Vietnam discovers 2,000 dead cats dedicated to traditional medicine
Chinese Prefer Traditional Medicine Against Coronavirus
Traditional medicine against Corona.
Who's the winner?
The use of home remedies during the pandemic to treat Covid-infected people increased, including a green wormwood herbal drink promoted by the President of Madagascar as a treatment.
The plant has been shown to be effective in treating malaria, but its use to combat COVID-19 has been widely scorned by many doctors.
In China, traditional medicine has a long history, but major European medical bodies have previously requested that it be subject to the same principles of regulatory oversight as traditional medical methods.
John Ryder, head of research at the World Health Organization, said: “Scientific progress in traditional medicine must be subject to the same rigorous standards as in other areas of health. ”
The use of traditional medicine in the absence of rules
Of the 194 WHO member states, 170 have recognized their use of traditional and complementary medicine since 2018, but only 124 have reported laws or rules for the use of herbal medicines, while only half have a national policy on such methods and medicines.
According to the World Health Organization (WHO), “natural treatment does not always mean it is safe, and centuries of use are not a guarantee of effectiveness; therefore, the scientific and practical method must be applied to provide the accurate evidence required. ”
About 40% of approved pharmaceutical products currently in use are derived from a “natural product basis, ” according to the World Health Organization, which cites“ prominent drugs ” derived from traditional medicine, including aspirin, based on formulations using willow bark.
More from the middle gate.
Related Titles
Washington Condemns Russian Attacks on Ukrainian Infrastructure Facilities in...
Zelensky: First cargo ship to sail through Black Sea ‘ important step ’
Canada's northernmost city ordered to evacuate as fires widen
Ukrainian Foreign Minister: We seek to strengthen our relations with Africa
Ukrainian Foreign Minister: We want to liberate our entire territory, no matter how long it takes
More...
Most preferred in this section.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Establishing rules for the safe, fair, and effective use of traditional medicine

The WHO is guiding policies and standards for safe traditional medicine use.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

Establishing rules for the safe, fair, and effective use of traditional medicine

Only 124 WHO member states regulate herbal medicines, which often lack proven scientific value.

India seeks Ayurveda's inclusion in WHO's ICD-11 list to enhance reporting and enable insurance coverage.

Title:

Content: Traditional Indian medicine set to make a global debut, seeking inclusion in WHO’s ICD-11 list

The inclusion of Ayurveda and related systems on the WHO list will provide it with a common language that allows health professionals to share standardised information across the world

October 14, 2023 06:17 pm | Updated 06:17 pm IST - NEW DELHI

A view of the World Health Organisation headquarters.

In a move meant to put the Indian system of medicine on the world map and provide it with a common standardised language, the Union government has sought for Ayurveda and related systems to be included in the 11th revision of the World Health Organisation’s International Classification of Diseases (ICD), as the second module of a supplementary chapter on traditional medicine conditions.

The ICD provides a common language that allows health professionals to share standardised information across the world. The traditional medicine module of the 11th revision provides a list of diagnostics categories to collect and report on traditional medicine conditions in a standardised and internationally comparable manner.

Speaking exclusively to The Hindu about the development, Ministry of Ayush Secretary Vaidya Rajesh Kotecha said: “We are hopeful that the addition of Module-2 for Ayurveda could happen as early as by next January.”

To aid regulation, research

“Ayurveda and related Indian traditional health care systems are formally recognised and widely practised health care systems in India, which is making a strong and valid point for its inclusion,” said Mr. Kotecha, adding that efforts to effectively regulate traditional medicine as an integral part of the health system require standardised and evidence-based information.

Mr. Kotecha further explained that the traditional medicine chapter under ICD-11 is a formative step for the integration of such forms of medicine into a classification standard used in conventional medicine. “It also provides the means for doing research and evaluation to establish its efficacy,” he said.

The Ministry added that this chapter would also help to respond to growing demands for more and better regulation of traditional medicine, and its integration in mainstream health care and health information systems.

ICD-11 covers Chinese medicine

After a decade of repeated consultations, ICD-11 had facilitated the inclusion of Module-1, which covers traditional medicine conditions originating in ancient China, which are now commonly used in China, Japan, Korea, and elsewhere around the world.

The eleventh revision contains around 17,000 unique codes and more than 1,20,000 codable terms, which are now entirely digital. ICD-11 came into effect from January 2022.

The joint use of ICD-11’s chapter on traditional medicine along with other chapters on neoplasm, patient safety, and injuries, can enhance the reporting of adverse events. It will enable the integration of traditional medicine into insurance coverage and reimbursement systems, in line with larger WHO objectives relating to universal health coverage. It will also link traditional medicine practices with global conventional medicine’s norms and standard development.

The development of Module-2 for Ayurveda-related diagnostic systems is being actively supported by the Ministry of Ayush. It extensively banks on the implementation experience gained on the ground by the National Ayush Morbidity and Standardised Terminologies Electronic portal, and the Ayush Health Information Management System, the Ministry said.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products

The Ministry of Ayush is supporting regulation and standardization of Ayurveda.

The Indian government has a grievance cell for public complaints, including concerns about herbal remedies.

The Union Health Ministry regulates drug quality in India, including herbal remedies.

Title:

Content: Nation

Mandaviya chairs 2-day regulators’ Chintan Shivir

New Delhi: As Union Health Ministry’s two-day “Chintan Shivir” on Drug Quality Regulation and Enforcement commenced on Saturday in Hyderabad, the brainstorming session deliberated on unified IT intervention all regulatory activities, effective enforcement at field level, Indian pharmacopeia and adherence to standards, and capacity building of state and national regulators.

According to the Health Ministry’s official communiqué, the sessions are aimed at creating interaction with stakeholders, with a view to evolve a participative approach for time-bound implementation of policies and programmes.

The session was chaired by Union Health Minister Mansukh Mandaviya.

“The objective of the two-day Chintan Shivir is to review processes and implementation of policies and programmes related to drugs quality and enforcement in the country,” it said, adding that

the meeting will also recommend ways and means for facilitating ease of doing business by reviewing predictability, transparency and compliance to Indian drug standards, regulatory capacities across states and centre.

Participants will also discuss global best practices, introduction of newer interventions like digital tools, clinical trial standards and in-turn give an impetus towards creating a multi-stakeholder approach for the benefit of common citizens, the ministry release said.

At the brainstorming session, eminent speakers along with domain experts from government, industry, startups, academia have also participated.

Next Story

The Indian pharmacopeia ensures the safety and efficacy of herbal remedies.

Standards are established for herbal remedy safety and regulators are built up to ensure compliance.

Title:

Content: Nation

Mandaviya chairs 2-day regulators’ Chintan Shivir

New Delhi: As Union Health Ministry’s two-day “Chintan Shivir” on Drug Quality Regulation and Enforcement commenced on Saturday in Hyderabad, the brainstorming session deliberated on unified IT intervention all regulatory activities, effective enforcement at field level, Indian pharmacopeia and adherence to standards, and capacity building of state and national regulators.

According to the Health Ministry’s official communiqué, the sessions are aimed at creating interaction with stakeholders, with a view to evolve a participative approach for time-bound implementation of policies and programmes.

The session was chaired by Union Health Minister Mansukh Mandaviya.

“The objective of the two-day Chintan Shivir is to review processes and implementation of policies and programmes related to drugs quality and enforcement in the country,” it said, adding that

the meeting will also recommend ways and means for facilitating ease of doing business by reviewing predictability, transparency and compliance to Indian drug standards, regulatory capacities across states and centre.

Participants will also discuss global best practices, introduction of newer interventions like digital tools, clinical trial standards and in-turn give an impetus towards creating a multi-stakeholder approach for the benefit of common citizens, the ministry release said.

At the brainstorming session, eminent speakers along with domain experts from government, industry, startups, academia have also participated.

Next Story

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Establishing rules for the safe, fair, and effective use of traditional medicine

India's regulatory framework bridges traditional and modern medicine for phytopharmaceuticals.

Title:

Content: Chairman of the Board of Directors and Editors
I'm sorry.
Mohamad Elbaz
Chairman of the Board of Directors and Editors
I'm sorry.
Mohamad Elbaz
Medicines Authority advises citizens to ensure registration of herbal medicines
The Egyptian Medicines Authority (EMA) has advised on the need to ensure the registration of herbal medicines in the authority, pointing out that over the past three decades, the use of herbal preparations has increased significantly with a large sector of people around the world relying on them in part of primary health care.
The Authority pointed out that herbal medicines, like any other medicines, must be registered with the Egyptian Drug Authority, to ensure their safety, quality and effectiveness, as they pass strict tests by the Egyptian Drug Authority, and are subject to supervision.
She added that herbal medicines are registered with the Egyptian Medicines Authority, to ensure quality standards, safety of use and therapeutic effectiveness.
- Quality control workshop for pharmaceutical companies
In a related context, the Egyptian Drug Authority announced the opening of registration in a workshop to introduce the accreditation program of the Egyptian Drug Authority for quality control laboratories in pharmaceutical companies, which aims to introduce the accreditation program of the Egyptian Drug Authority for quality control laboratories in pharmaceutical companies.
She added that the workshop is scheduled to be held on Monday, June 19, at the headquarters of the Egyptian Drug Authority in Mansouria, pointing out that the workshop is an introduction to the managers of quality control and assurance laboratories and registration officials in pharmaceutical factories and companies.
She pointed out that the workshop starts from 9: 30 am to 3: 30 pm.
The deadline for participation and payment of the fees for the training is Thursday, June 15, and the trainee will receive a certificate of attendance approved by the Egyptian Drug Authority Center for Continuing Professional Development.

India has the world's oldest medical cannabis regime, with Ayurveda recognizing it as a medicinal plant.

The global medical cannabis industry is expected to hit USD 100 billion by 2028, and Ayurveda records over 200 classical cannabis-based formulations.

Title:

Content: Explainers
NEWS
12 hours ago

Does India Have Patience, Will And Resources To Build World's Top Cannabis Medicine Industry?

Raghav PriyadarshiUpdated on Mar 27, 2022, 16:03 IST

Consider the size of the opportunity — today’s billion dollar global medical cannabis industry is expected to hit USD 100 billion by 2028. That’s a 100x growth in the next six years.

We’ve missed the bus once — India is the largest producer and exporter of licit opium in the world, contributing over 50% of global volumes. Yet there is not a single Indian firm that is a global leader in manufacturing opioid medications, a USD 40 billion market annually!

Unspash/Representational image

On the back of successful medical cannabis regimes in countries such as Canada, Germany and increasingly the United States, hundreds of thousands of patients are able to access medical cannabis to treat a host of chronic conditions, most of which do not have safe or effective treatment pathways – neuropathic pains such as sciatica, fibromyalgia, and cancer-related pains; rheumatic conditions such as arthritis and multiple sclerosis; neurological conditions such as insomnia, migraine and Parkinson’s; or the ever increasing burden of mental health issues such as anxiety and depression – all conditions in which cannabinoid medicine has demonstrated ground-breaking results.

In this scenario, it is important to remember and highlight that India has the oldest medical cannabis regime in the world – in the form of Ayurveda – which records over 200 classical cannabis-based formulations. While Ayurveda recognises cannabis as a medicinal plant, allopathy does not.

Thus, modern formulations containing cannabis compounds cannot be manufactured and marketed with approvals from India’s drug regulator, until clinical research establishes the safety and efficacy of cannabis compounds in treating any particular condition. The onus is thus on the Indian pharmaceutical industry to undertake the required research to establish cannabinoids as therapeutic agents.

Unsplash/Representational image

Plant-derived drugs have tremendous potential, and the global pharma industry has barely scratched the surface of developing modern therapeutic formulations from medicinal plants. A case in point is ‘Artemisinin’, first extracted from Sweet Wormwood by Tu Youyou, a Chinese chemist who was awarded the Nobel Prize for Medicine in 2015 for demonstrating the efficacy of Artemisinin in treating malaria.

Tu Youyou drew inspiration from Traditional Chinese Medicine texts to find a cure for malaria, texts which prescribed using Sweet Wormwood to treat various fevers. Similarly, India too enjoys a unique position to build on the thousands of years of traditional medical knowledge contained in Ayurveda, to create novel therapeutics for unmet medical needs of the 21st century.

Cannabinoid medicine is projected to be the fastest growing life-sciences sector over the coming decade. Tapping this opportunity requires a change in mindset of Indian pharma, graduating from generic medicine manufacturing to R&D-based novel drug development. India has the necessary ecosystem – scientists, clinicians, researchers, a large drug manufacturing ecosystem and very large patient population – to really catapult the Indian life-sciences industry, and in particular cannabinoid therapeutics firms into global leaders.

Unsplash/Representational image

Cannabinoids have the potential to capture a significant share of this market with safer and effective alternatives to opioids and other analgesic medicines. The Indian drugs regulator has even issued regulations for a new class of plant-based drugs – ‘phytopharmaceuticals’ – a perfect bridge between traditional medicine manufacturing and modern allopathy.

Yet, seven years after the establishment of this hybrid regulatory regime, the Indian pharmaceutical industry is yet to respond with novel formulations registered under this category of medicine. It is high time we change our mindset, focus on value-added drug development, play by the rules of global pharma with respect to quality, safety and efficacy standards, and win!

The author is the founder and Chief Executive Officer of Savikalpa Sciences, a cannabinoid-focussed pharmaceutical firm. The views expressed in the article are author's own.

What is the traditional Indian medical system called?

Cannabinoid medicine treats chronic conditions like neuropathic pains and is regulated by the Indian drugs regulator.

In what areas have the medical uses of traditional Indian medicine been studied?

Treatment on pain
Treatment on neurological conditions

The WHO has called for strengthened quality control and laws against substandard medicines.

Title:

Content: In India, of the nearly 89,000 drug samples tested, more than 2,500 failed to meet the standards.
Such data was presented by the Minister of health of the country Mansuh Mandavia, reports Reuters.
About 380 samples were found to be fakes.
The government of India has allocated about $80 million to the Ministry of Health to strengthen the drug regulatory system, including the creation of laboratories for testing new drugs and the modernization of existing ones.
Over the past 10 years, exports of pharmaceuticals from India more than doubled to $24.5 billion in 2021-2022.
However, the deaths of 20 children in Uzbekistan and 200 in the Gambia and Indonesia after taking children's antipyretic syrups from Indian companies, in which ethylene glycol was found, undermined India's image as a "world pharmacy," the newspaper notes.
Last week, the Indian manufacturer Global Pharma Healthcare was also forced to withdraw all batches of its eye drops, as the United States registered 55 cases of side effects associated with taking the drug, including eye infections, irreversible loss of vision and one death, writes The Hindu BusinessLine.
At the end of January, the World Health Organization called on drug manufacturers to strengthen quality control of raw materials and the manufacturing process.
Governments should enact laws to combat substandard and falsified medicines and strengthen market surveillance, including informal surveillance.

India has allocated $80 million to strengthen drug regulation, with pharmaceutical exports now at $24.5 billion.

Title:

Content: In India, of the nearly 89,000 drug samples tested, more than 2,500 failed to meet the standards.
Such data was presented by the Minister of health of the country Mansuh Mandavia, reports Reuters.
About 380 samples were found to be fakes.
The government of India has allocated about $80 million to the Ministry of Health to strengthen the drug regulatory system, including the creation of laboratories for testing new drugs and the modernization of existing ones.
Over the past 10 years, exports of pharmaceuticals from India more than doubled to $24.5 billion in 2021-2022.
However, the deaths of 20 children in Uzbekistan and 200 in the Gambia and Indonesia after taking children's antipyretic syrups from Indian companies, in which ethylene glycol was found, undermined India's image as a "world pharmacy," the newspaper notes.
Last week, the Indian manufacturer Global Pharma Healthcare was also forced to withdraw all batches of its eye drops, as the United States registered 55 cases of side effects associated with taking the drug, including eye infections, irreversible loss of vision and one death, writes The Hindu BusinessLine.
At the end of January, the World Health Organization called on drug manufacturers to strengthen quality control of raw materials and the manufacturing process.
Governments should enact laws to combat substandard and falsified medicines and strengthen market surveillance, including informal surveillance.

The WHO has proposed a global centre for traditional medicine in India to promote global health and wellness.

Title:

Content: For Quick Alerts
ALLOW NOTIFICATIONS
For Daily Alerts

Yoga Uniting World In Pursuit Of Good Health, Wellness, Says Prime Minister Modi

By

Prime Minister Narendra Modi on Saturday said yoga is uniting the world in pursuit of good health and wellness as he lauded the Indian embassy's "great effort" in Doha for holding a yoga session for people of 114 nationalities. In his tweets, Modi also referred to the Ministry of Ayush signing the 'host country agreement' with the World Health Organization for establishing the WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, and said India is honoured to be home to such a state-of-the-art centre.

"This centre will contribute towards making a healthier planet and leveraging our rich traditional practices for global good," he said.

Traditional medicines and wellness practices from India are very popular globally, he noted, adding that the WHO centre will go a long way in enhancing wellness in society.

The World Health Organization had earlier tweeted that it and the Indian government have agreed to establish the WHO Global Centre for Traditional Medicine to maximise the potential of traditional medicines through modern science and technology.

Story first published: Monday, March 28, 2022, 10:30 [IST]
Read more about: yoga wellness

The centre will use modern science to enhance traditional medicines and wellness practices.

Title:

Content: For Quick Alerts
ALLOW NOTIFICATIONS
For Daily Alerts

Yoga Uniting World In Pursuit Of Good Health, Wellness, Says Prime Minister Modi

By

Prime Minister Narendra Modi on Saturday said yoga is uniting the world in pursuit of good health and wellness as he lauded the Indian embassy's "great effort" in Doha for holding a yoga session for people of 114 nationalities. In his tweets, Modi also referred to the Ministry of Ayush signing the 'host country agreement' with the World Health Organization for establishing the WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, and said India is honoured to be home to such a state-of-the-art centre.

"This centre will contribute towards making a healthier planet and leveraging our rich traditional practices for global good," he said.

Traditional medicines and wellness practices from India are very popular globally, he noted, adding that the WHO centre will go a long way in enhancing wellness in society.

The World Health Organization had earlier tweeted that it and the Indian government have agreed to establish the WHO Global Centre for Traditional Medicine to maximise the potential of traditional medicines through modern science and technology.

Story first published: Monday, March 28, 2022, 10:30 [IST]
Read more about: yoga wellness

The WHO supports integrating traditional medicine, including herbal remedies like Ashwagandha, into modern healthcare.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Establishing rules for the safe, fair, and effective use of traditional medicine

The safety and efficacy of Indian herbal remedies are ensured through methods including artificial intelligence, chemical analysis, and spectrometry.

Title:

Content: ...
...
...
...
Private.
Yemeni pharmacist: I invented a way to control the quality of medicines with artificial intelligence
I'm sorry.
Abdulrahman Roshan talked to Arabia.net about how he invented a method that is the first in the world to detect the quality of herbal medicines
Posted in: Last Updated:
The Yemeni pharmacist, Abdulrahman Roshan, invented a new method in analyzing the quality of medicines made from a mixture of herbs by applying artificial intelligence techniques, to obtain his PhD from the Faculty of Pharmacy, Ain Shams University, for his thesis entitled: "Quality control of multi-herbal products using chemical analysis".
Results of a study published in a British journal
Discovered by dr.
Abdulrahman, a faculty member at the Faculty of Pharmacy, University of Aden, told Al-Arabiya that the method he followed is the first of its kind in the world, pointing out that he published some of the results in the British journal Phytochemical Analysis, which specializes in this field, and has a high impact factor (3.37) according to the assessment of Clarivate.
According to the Yemeni researcher, there are many medicines containing several plant components that have proven their effectiveness, but there is no optimal way to evaluate the quality of these products and confirm their ingredients.
A gateway to control the quality of medicines
I consider dr.
Dr. Abdulrahman said that this achievement represents a promising portal that helps in controlling the quality of these complex drugs, as well as the rediscovery of many of the therapeutic recipes mentioned in the books of the Arab medical heritage and the development of drugs of natural origin.
The biggest obstacle to global acceptance of these products is the availability of a reliable quality control method.
Significant Differences Between Modern Therapy and Folk Medicine
He drew dr.
Dr. Abdulrahman pointed out that the concepts and modern therapeutic methods differ from those followed in the systems of folk medicine, which often lack the scientific methodology, pointing out that the systems of folk medicine "Chinese and Arab" aimed to restore the overall balance of the body, where recently proven therapeutic recipes consisting of several plant extracts effective against specific diseases.
He explained dr.
Dr. Abdulrahman pointed out that this technique is based on recording the chemical fingerprint of the product using spectrometry or what is called "chromatographic analysis", where one of the recipes mentioned in the book of the law in medicine of Avicenna, as well as in the book "To the needy" by David of Antioch, which is registered in the Greek Pharmacopoeia adopted in India.
The results proved the ability of statistical models to distinguish between the preparation conforming to the specifications and the preparation not conforming to the specifications, in addition to estimating the quantities of herbs in all the samples of the study and with a high accuracy of not less than 95%.
According to dr.
Dr. Abdulrahman said that the aim of his research study is to develop appropriate methods for evaluating the quality of products made up of several plant herbs, provided that these methods are simple and more effective, and can be applied in developing countries, as the cost of access to modern devices is very expensive.
The reasons for the exodus of Yemeni doctors.
The proliferation of black drug markets
In his interview with Al-Arabiya, Dr. Abdulrahman Roshan said that the situation of the medical sector in Yemen has deteriorated significantly, especially in health care services due to the years of war and siege in all its forms, which contributed to the deterioration of the economic situation, the collapse of the currency and the increase in cases of malnutrition in front of the citizen's total inability to provide the price of food, treatment and medicine.
The weakness of state oversight bodies has also contributed to the proliferation of smuggled and corrupt drugs on the black market.
Added Fr.
Hashim said that the escalation of the conflict and the intensification of the indicators of poverty, led to the migration of doctors and minds abroad, in light of the government ’ s disregard and indifference to finding livelihood solutions that prevent the brain drain, which is a pillar of the development of any society.
Most Read Common Topics

What has been done to document Indian herbs regarding their active ingredients?

The global herbal medicine market is valued at $150 billion and is projected to reach $230 billion by 2027, led by Asia-Pacific.

Title:

Content: | | |
Press Release
Malaysia, China boost herbal supply chain by using digital herbal certificates in international trade
HANGZHOU, China, Dec. 8, 2021 / PRNewswire / — Following a dialogue on Sept. 29, 2021 between the Foreign Ministers of Malaysia and China, as well as cooperation in the field of traditional Chinese medicine on Dec. 4, 2021, in Hangzhou, the capital of Zhejiang Province, Good Health System Co., Ltd. (“GHS ”) of Qianhai-Shenzhen and GHHS Healthcare (GHSH) signed a) of Country Heights Holdings Berhad signed a memorandum of agreement during the ceremony held by the Foreign Ministers of Malaysia, Dato 'Saifuddin Abdullah, and China, Wang Yi, announcing bilateral cooperation with the renewal of a memorandum on traditional medicines by the competent authorities.
Under the memorandum of agreement, GHS is making efforts to facilitate the supply of high quality herbs to the people of Southeast Asian countries (ASEAN) by issuing digital “Herbomics ” certificates with GHHSH.
At the same time, both GHS and GHHSH are connected through China Construction Bank ’ s Labuan Branch (CCBL), where they are committed to providing an efficient financial solution to support international weed trade.
Dr. Xiang Chunyuan, founder of GHS, said: “We are also facilitating direct feedback from end users, which can be adopted in order to improve new drug formulations or improve management methods for the benefit of humans. ”
GHS is a digital biotech company specializing in the digital analysis “HERBOMICS ” based on classification calculations for both dynamic and static bio-matching systems.
One of the main services provided to customers is the certification of plant raw materials from the beginning until they reach the buyers.
GHS has created a closed-loop, secure and convenient digital service platform to increase trust in global herbal supplies.
This happens through the introduction of the GHS code, where the code complies with international regulations and standards in the field of health, plant raw materials and international supply chains.
About GHS
Herbal medicine has been widely used around the world for centuries in different cultures.
Although the world has not recovered 100% from this epidemic, people and scientists are now more open than ever to high-quality natural remedies such as “herbs ” for health care as well as research and innovation trends.
Using artificial intelligence and cloud computing, based on networking and the digitization of matching weed biometrics for chemical quantitative studies, GHS provides timely, real-time analysis along with the long supply chain of raw herbs.
GHS services are available via the app to enhance the supply of high quality products to pharmaceutical companies, retail stores, end users, etc.
In 2020, the global herbal medicine market reached US $150 billion and is expected to grow to US $230 billion by 2027, with the Asia-Pacific region accounting for 50% of the market.
The GHS and GHHSH will define working arrangements to promote the overseas weed trade in the ASEAN region.
Photo – https: / / mma.prnewswire.com / media / 1704058 / Signing _ Picture.jpg
The Iran News Gazette is mainly concerned with news and information about the Arab region and also covers international issues.
Its main objective is to provide reliable and verified information on the Arab region for publishing on the digital landscape.

The Indian government has set new standards for pharmaceutical manufacturing, requiring ingredient testing before product marketing.

Title:

Content: World News
India orders new standards for pharmaceutical manufacturing
ABU DHABI (Reuters) - India ’ s pharmaceutical companies must set new manufacturing standards this year, according to a government notice issued on Saturday.
The notice, dated December 28, states: “The manufacturer must take responsibility for the quality of the products to ensure they are suitable for their intended use, comply with licensing requirements and do not put patients at risk. ”
The notification added that companies must market the finished product after achieving “satisfactory results ” in testing the ingredients.
India ’ s health ministry said in August that inspections at 162 pharmaceutical plants since December 2022 had revealed a “lack of testing for incoming raw materials. ”
Fewer than a quarter of India ’ s 8,500 small pharmaceutical factories comply with international standards for the manufacture of medicines set by the World Health Organization (WHO), the ministry said.
The notification stated that these concerns should be addressed by major pharmaceutical companies within six months and by small manufacturers within 12 months.
Advertisements
You may also read.

The CDSCO aims to protect public health in India, but enforces Good Manufacturing Practices loosely.

Title:

Content: Drug Regulation Trade Secret

IP Reveries: Class 5.2 – Interrogating India’s Drug Regulation System

CDSCO Vision – To Protect and Promote Public Health in India.

Prof Antilegend is back to greet you all on this yuletide! After brooding over the basics in the last class, this session (i.e. class 5.2) sieves through the Indian drug regulation system, which has attracted much attention in the last few months. For the previous class, please go here. And if this is your first time coming across the IP Reveries series, you can see what it is about as well as get links to our previous classes in the introductory post here. IP Reveries is co-authored by Swaraj Barooah and myself. For these classes that touch upon Indian drug regulation, we’d like to give a shout out of appreciation for the works of Prashant Reddy T & Dinesh S Thakur which we have learned and are tremendously learning from.

Interrogating India’s Drug Regulation System

Prof. Antilegend: Hello Stars, good morning. Now that you have got an inkling of the drug innovation process from the last class, let’s dig a little bit into the realm of (dodgy?) drug regulation. (smiling)

Slato: Yes. Those readings, that you suggested, gave us a bit more of an introduction to this whole pharmaceutical IP and non-IP world. But Prof. … so much information, trials, waivers and whatnot, we’ll have to break it down.

Prof. Antilegend: Yes, yes, we will need to. Why don’t we start with you telling me what stood out to you from your reading so far? Any particular part that you’d like to start with?

Pocrati: Hmm… I seem to have gathered several small bits of information but not sure how to piece it all together.

Prof Antilegend: Sure, let’s tread with your troves of information.

Pocrati: Okay, So… It appears that in India, regulatory approval for the import, manufacture, distribution and sale of drugs is still governed by the pre-independence Drugs and Cosmetics Act, 1940 (along with some associated Rules). Is this actually the law that governs current medicine too? In any case, as per this regulatory setup, manufacturers of ‘new drugs’ need to submit data from the different phases of clinical trials, including trials conducted within India, to the regulators for them to check if it’s safe and provides the benefits it claims to. Here you may ask – what are ‘new drugs’? Well, while you can find exact details in the legislative provisions, for purposes of our current discussion, what I’ve understood is that the “new drugs” label is given to those that haven’t received regulatory approval in the form or combination that is sought to be sold; it is also given to novel drug delivery systems, or biologics/vaccines. This ‘new drug’ status lasts for 4 years, except for biologics/vaccines which are considered ‘new drugs’ indefinitely.

Feus: Wait – what does that mean … if it’s 3 years old, it’s still new? What’s the point of this legal fiction?

Prof Antilegend: Good question. What this means is that if you want regulatory approval for a drug that hasn’t been sold in India before, then you will need to submit clinical trial data to the regulators for approval. If your drug is approved, then for the first 4 years of approval, it will continue to be considered a ‘new drug’. This means that if anyone else also seeks to sell their version of that drug, they too will need to submit clinical trial data, even though your version of the drug has been approved. And as we’ve seen in the previous class, this is very expensive and time-consuming, and it automatically reduces the number of potential competitors. And this requirement remains for 4 years after the first approval, unless it is a vaccine or biologic drug. So far, so good, right? You can get a better idea about this from this reasoned report, see paragraphs 142-143.

Akira: Wait … isn’t this a bit duplicative? And perhaps ethically questionable? Repeating expensive trials on human subjects, for drugs that have already received approval?

Prof. Antilegend: It might be and there’s a whole additional ‘data exclusivity’ debate waiting for you if you go there. But – as it turns out, the question to be asking is whether this actually plays out this way in practice! (And let’s not even go into the practice of regulation of manufacturing standards and other details!!)  In reality, it is often the case that new drugs are introduced into the Indian market after they have received foreign regulatory approval. Resultantly, the Indian drug regulator normally exempts manufacturers or importers of a new drug to submit trial reports and grants approval on the basis of bioequivalence and bioavailability tests.

Feus: bio-equivalence … available tests … What’s that now?

Prof. Antilegend: Essentially, these tests show that the concerned drug produces the same effect at the same rate, as the already approved drug.

Nya: Okay … and (confused face) Prof., you also said that once approved in other markets, they are generally accepted in India. But then those drugs must have been tested primarily on foreigners with different genetic compositions. How ethical and logical is it to assume that tests conducted in the X part of the world on a certain population with different genetic dispositions be suitable to the population of our country (again with a much more diverse population)? This is a matter of health, the mere availability of *a* vaccine/medicine isn’t always the answer. It should be effective as well as safe in the long run. No? What about their testing requirements on the Indian population

Prof. Antilegend: Hm. Technically, Yes, there is a requirement for local trials to ensure that drugs work well on the Indians. In fact, the 59th Parliamentary report on CDSCO highlighted this point noting that:

There is evidence that the effect of some drugs can vary among various ethnic groups. For example, the blood levels reached after intake of lipid lowering agent rosuvastatin are far higher in Asians, compared to Europeans and North American Caucasians, Hispanics and Blacks needing lowering of dosage. Failure to lower dose in Indians can result in severe toxicity, including life-threatening muscle injury leading to fatalities. Hence, testing drugs in the Indian ethnic groups is of paramount importance before approving any drug of foreign origin.” (¶ 7.10)

However, like other things, they can also be waived in the “public interest”. From what I have understood so far from reports and articles is that these waivers have become the norm, meaning that no/very few generic companies conduct these trials before getting approvals in India. Please go searching for data on this though, if you can find any! But note, generic companies are still required to submit bioequivalence and bioavailability studies without any exceptions when a drug is new i.e. in the initial 4 years. (with a pause) Although it’s a different discussion that some Indian Clinical Research Organisations have fudged even them. Anyway, You can read about them after class here, here, and here.

Pocrati: Wait, with so many tests, I am a bit confused now. Please confirm this – there is one test of bio-equivalence/availability in the initial 4 years period when a drug is ‘new’. This is to enter the market and escape clinical trials. Correct? And there is another test on the Indian population to confirm the therapeutic efficacy which is waivable. Okay? But (curiously) what happens after 4 years when a drug loses the label of “new drug”?

Prof. Antilegend: Yes, you are correct. Regarding your question – the answer is a bit bizarre.  So … before 2017, even the bioequivalence/bioavailability studies were not required after 4 years. But then came a notification which mandated these bioequivalence/availability tests for certain classes of drugs (not treading into the technicalities here!). But this notification only has a prospective application. This means that before 2017, those generic companies which applied for approval (which they generally did) after 4 years may not have submitted these tests. What this means is that we are very likely to have some ‘untested’ drugs in the market today and the 2017 notification can’t help it.

Slato: Oh, sounds damn dangerous!!!

Prof. Antilegend: Exactly, it is! This issue was raised by the Ranjit Roy Choudhary Committee which recommended making these studies mandatory for all generics. (Unfortunately, the report itself doesn’t seem to be available online anywhere – so if any of you can share it, we could share it with the rest of the class!) Sadly, the CDSCO’s drugs consultative committee consisting of state drug controllers and the Drug Controller General of India rejected this recommendation on commercial grounds. There were even FIRs filed that asked, among other things, for the mandating of these tests for all the generics, but were dismissed as raising issues of only “academic interest”.

Pocrati: That’s sad though I am glad that something happened finally in 2017. But for ‘untested drugs’ that actually go wrong and harm people – there would be some harsh punishment, no? What are those punishments? Even in the Gambia tragedy, I believe that the accused drug manufacturer would be banned now from manufacturing drugs. Please tell us a bit about that.

Prof. Antilegend: Speaking ideally, yes, a minacious manufacturer should face harsh punishments. But now speaking legally, it is not the case in India, sadly! On paper, the highest punishment is 10 years which can be extended to life imprisonment with a fine of 3 lakhs when the drug causes or is likely to cause death. And, for a sub-standard drug, the punishment is between 1-3 years with a fine. However, health researchers and activists say that it does not happen in practice, (sometimes it even turns out that most punishments are just for sitting one day in court!). And what further flaws this fettle is the recent Drugs, Medical Devices and Cosmetics Bill 2022 lowering these punishments.   The Bill, under its Section 56(e), establishes a new category of offences relating to the production or distribution of misbranded medications Technically, this is about “NSQ” drugs i.e. drugs “not of standard quality”! The bill, in its fourth schedule, mentions 43 manufacturing-related defects for which the lowest punishments can be given i.e. imprisonment of up to one year and a fine of at least two lakh rupees. And the defects which are not in the “43 defects list”, the manufacturer is liable for a higher punishment of up to 2 years imprisonment and a fine of Rs 5 lakh.

Coming to the Gambia incident, things are in utter uncertainty – while the Drugs Controller General of India gave a clean chit to Maiden Pharmaceuticals saying that the drugs complied with standards and has no diethylene glycol (DEG), a Geneva lab revealed otherwise claiming the presence of the toxin DEG in impugned syrups. So, no punishment as such except Haryana Government’s order to stop the manufacturing. It is important to note here it is not the first time Maiden Pharmaceuticals to create a cause of consternation! See this image prepared by an Indian newspaper:

Source – Times of India

Slato: But there must be some “Good Manufacturing Practices” that manufacturers should adhere to. Can you give any examples from this “43 defects” club?

Prof. Antilegend: Good question. Yes, there are some good practices but no-following them is not punishable by our laws. And for the examples … (thinking) … it includes “heavy metals” and “particulate contamination/foreign matter”. Meaning that if a medicine is found to have metals, fungus, or glass particles (which are supposedly dangerous for our consumption), the manufacturer will receive a reduced sentence or maybe no imprisonment at all! Note, the story does not end here – the Bill even has a compounding provision in Section 71 which means that the trial and prison time for the offence can be waived as long as the manufacturer agrees to pay the fine. Moreover, Section 58 even empowers the government to expand the list of exceptions i.e 43 defects lists with the lowest list can be expanded. …

Feus: Prof., I think we should definitely do something about it. But let’s start with taking a break and coming back with more mental mettle! (with a smug)

Prof. Antilegend: Sure. Although I have a few more things to discuss, I want someone to summarise this class, relating it to the previous class.

Sugastine: Yes, I can do it. So …  first, we had a ‘theoretical’ session about drug innovation, its stages, tests etc. Then, in this class, we discussed the practicality of the previous class as to how drug innovation actually works in India. Here, we saw the dire state of our drug regulation, the increasing discretions (and discrepancies) and decreasing punishment and checks. Anything left?

Prof. Antilegend: Fair enough. In the next class, let’s mix theory and practical understanding and deliberate on the future of drug regulation and come back to where we started – “test data”, its importance and implications. But before you leave, here’s a reading recommendation –  Allison Durkin, at el.’s Addressing the Risks That Trade Secret Protections Pose for Health and Rights.

Mindy: Sure, see you in the next class. Thanks

(steps of the students leaving the class)

Image from here

Lokesh Vyas

Lokesh graduated from the Institute of Law Nirma University (2021 batch) and won the first edition of the Shamnad Basheer Essay Competition, 2020. He is currently pursuing an LLM from the American University Washington College of Law and working as a researcher at the Program on Information Justice and Intellectual Property (PIJIP). He is a recipient of the Arcadia Fellowship and Arodhum Scholarship.

India's drug regulation is governed by the Drugs and Cosmetics Act, 1940, which requires clinical trial data for new drug approvals.

The WHO centre for traditional medicine will help countries integrate traditional medicine into their health systems using AI and big data.

The Indian government has allocated $250 million for the WHO Global Centre for Traditional Medicine.

The centre will use AI and big data to study and standardize traditional medicine.

The WHO recognizes traditional medicine's importance, used by 80% of the world's population, with 40% of approved drugs derived from natural substances.

Ashwagandha has anti-inflammatory properties, reduces anxiety, and improves sleep and mental function.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
The controversial Ashwagandha herb on social media..
Everything you need to know about her
Ashwagandha is a medicinal herb used in traditional Indian medicine (Ayurveda) for centuries and has become controversial on social media due to some interesting claims about its potential benefits.
However, we should treat this information with caution and regard it as public information.
Dr. Abdulrahman Shams, a nutritionist, revealed in special statements to Sada Al-Balad, the following are some of the main points of your knowledge of this herb and the possible allegations about it:
1.
Traditional use: Ashwagandha is believed to have soothing, anti-inflammatory and anti-stress properties.
It has been used in the Indian tradition to treat a variety of conditions such as stress, anxiety, sleep disorders and fatigue.
1.
Scientific research: There are some scientific studies that support some of the potential benefits of ashwagandha.
Some research has shown its potential effect in reducing anxiety levels, improving sleep, and supporting mental functioning.
However, more research is still needed to confirm the efficacy and safety of this herb.
1.
Side Possibilities: Typically, ashwagandha is considered safe when taken in moderate doses.
However, some minor side effects such as drowsiness or digestive disorders may occur.
Consult your doctor before taking ashwagandha, especially if you have an existing medical condition or are taking other medications.
1.
Drug interactions: Interactions may occur between ashwagandha and some other drugs.
It is advised not to take ashwagandha if you are taking medications such as antibiotics, depression inhibitors or thyroid medications, unless you consult your doctor.
You should remember that ashwagandha is not an officially recognized remedy for any health condition.
If you are considering using them, you should consult your physician or use a specialist healthcare practitioner for personal advice and guidance appropriate to your individual health condition.

In what areas have the medical uses of traditional Indian medicine been studied?

Treatment on mental health disorders
Treatment on neurological conditions

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

Ashwagandha treats stress and fatigue by balancing hormones and reducing cortisol levels.

Title:

Content: Healthy Directions Partners with Dr. Kulreet Chaudhary to Combine the Tradition Of Ayurvedic Practice with Modern-Day Science

Bethesda, Maryland, UNITED STATES

BETHESDA, M.d., March 14, 2023 (GLOBE NEWSWIRE) -- In Ayurvedic medicine, the body, mind and spirit are treated using a holistic approach. Part of the practice is the use of essential herbs that have been revered for millennia, and are now supported by a growing body of scientific evidence. This pairing of traditional use with clinical science creates uniquely modern Ayurvedic blends that can serve as a bridge to a new world of health and vitality. This is the motivation for neurologist and Ayurvedic practitioner, Dr. Kulreet Chaudhary’s development of Prajna Ayurveda herbals with Healthy Directions, which she says have a remarkable ability to reset and restore the body and mind.

Integrating traditional Ayurvedic practices and modern-day science has been Chaudhary’s method for decades and has helped her successfully restore thousands of patients back to health, as well as transform her own health. Partnering with Healthy Directions, an established 30-year-old manufacturer and marketer of doctor-formulated nutritional supplements, has empowered Chaudhary to develop herbal formulas made with powder from the whole plant, as it has been used for thousands of years, along with powerful extracts of the plant that have been clinically researched for specific health benefits.

“What impresses me about Healthy Directions is how well developed they are as a company in terms of the mind and the heart, and particularly the heart,” said Chaudhary. “The heart is the source of all healing in Ayurveda, so for me, it was so important to make a decision to partner with people who I know are heart-centered, and who really care about their customers.”

The literal meaning of Prajna (Praw-g-ńa) is “transcendental wisdom,” which in Ayurveda refers to the peace and balance that comes from being fully present in your body and mind. Chaudhary says it is the ultimate expression of wellness. There are four essential herbs that make up the foundation of all the Prajna Ayurveda formulas. These herbs are among Ayurveda's most trusted herbal medicines, that Chaudhary says can bring about transformational shifts in your physical health and overall well-being:

  • Prajna® Triphala is taken at night to cleanse and “sweep” the day away. This lesser-known herb has been traditionally used to support digestion and elimination, while also nourishing both mind and body for the day ahead.
  • Prajna® Ashwagandha is a popular “multi-tasker” herb that brings daily harmony, calm, and positivity by helping balance hormones and reducing levels of cortisol—the body’s primary stress hormone.
  • Prajna® Brahmi has been used by Ayurvedic practitioners for centuries as a tonic for overall mind and memory support as well as for its calming effects on the nervous system.
  • Prajna® Guggul is a purifying Ayurvedic herb traditionally used for its cleansing effects and to support a healthy inflammatory response and cholesterol health.

The Prajna Ayurveda herbs by Healthy Directions are responsibly sourced in India, blended traditionally, produced in vegan capsules, triple-tested to assure quality, purity and potency and contain no hidden allergens such as gluten, dairy, egg or soy. Each affordably priced product is balanced for use by all three Ayurvedic mind-body dosha types, and incorporates Ayurvedic healing practices of sound medicine and sacred geometry. As part of the Prajna Ayurveda product line, Chaudhary has also developed the Veda Wellness products that uses essential Ayurvedic herbs with clinically-studied ingredients for modern-day health concerns, including: Veda Rescue, Veda Lean, Veda Balance Brain and Veda Balance Gut to target specific health concerns. Learn more about Dr. Kulreet Chaudhary’s Prajna Ayurveda herb line and “Om Namo Narayani” (I honor the divine energy that resides in all of us) at: https://www.healthydirections.com/dr-kulreet-chaudhary.

About Healthy Directions: Healthy Directions LLC, a subsidiary of Wellful LLC, is a leading provider of premier doctor-formulated nutritional supplements and skincare products. Celebrating 30 years of providing expert natural health guidance from some of America’s most knowledgeable and highly respected integrative and alternative health doctors, including Dr. Julian Whitaker; Dr. David Williams; Dr. Stephen Sinatra; Dr. Drew Sinatra; Dr. Briana Sinatra; Dr. Kulreet Chaudhary, Dr. Rudrani Banik, Dr. Ken Redcross and Dr. Joseph Pergolizzi, Jr. Learn more at: https://www.healthydirections.com/about-us.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/98eaae2d-7655-49e2-8ebd-2000394a053c

https://www.globenewswire.com/NewsRoom/AttachmentNg/e9e36fb5-0a2e-42a6-8d78-1913fc824c89

https://www.globenewswire.com/NewsRoom/AttachmentNg/52092125-bbf1-42f1-8678-9e0095707325

Video accompanying this announcement is available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/aa418877-d78d-4fd7-a636-9f85666f0d55

Contact Data

In what areas have the medical uses of traditional Indian medicine been studied?

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

In what areas have the medical uses of traditional Indian medicine been studied?

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

Turmeric helps control blood sugar, limiting the harmful effects of other drugs, making it useful for treating Type 2 diabetes.

In what areas have the medical uses of traditional Indian medicine been studied?

Ayurvedic remedies like Turmeric treat diabetes with limited side effects through lifestyle modification and detoxification.

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

Indian herbal remedies like Ashwagandha and Turmeric modulate the gut microbiome, reduce inflammation, and balance hormones.

Title:

Content: Current research on gut microbial modulation with culinary herbs and spices

An article published in Food Chemistry elaborated on the health benefits of culinary herbs and spices. It stated that these plant extracts harbor the potential for prebiotic effect, owing to their polyphenol content. The bioactive constituents likely harbor anti-inflammatory properties and modulate the gut microbe. Using herbs and spices could prevent certain diseases associated with impaired gut barrier function and obesity.

Background

Many branches of alternative medicine, like Ayurveda, Siddha, and Unani,  originated in India. The use of spices and herbs for medicinal purposes is an age-old practice, used even today – owing to the anti-inflammatory and antioxidant properties of these plant extracts and their high polyphenol content.

The fresh aerial parts (leaf and flowers) of certain plants are used as culinary herbs, whereas the dried remainder parts are used as a culinary spice. In Ayurveda, herbs and spices are not only used for promoting health but also for disease prevention.

Many herbs are used for treating mild gastrointestinal disorders, for instance, ginger for indigestion, turmeric during jaundice, licorice to attenuate gastrointestinal discomfort, and mint supplements during irritable bowel syndrome (IBS). Herbs and spices are also used to ward off complications related to obesity, cardiovascular diseases, stroke, and certain cancers.

The Mediterranean diet includes many herbs and spices, which renders its anti-inflammatory and oxidative stress reduction potential. Although there are indications for using herbs and spices for medicinal purposes, thorough scientific investigation is warranted before their prescription for health benefits.

The gut microbiome comprises bacteria, viruses, and eukaryotes. The colon and the large intestine harbor approximately 3.8 x 1013 microbes; the majority are bacteria. The gut microbiota can be categorized in many ways and differs according to the host’s age, dietary pattern, health status, environment, and medication use.

Identifying and characterizing the gut microbiota can be culture-independent (for example, fluorescent in situ hybridization or FIAH) or culture-dependent (traditional method of bacterial plating). The advanced culture-dependent method also exists, like meta-genomics sequencing, polymerase chain reaction (PCR), DNA sequencing, and immunoglobulin A sequencing.

Functions of the gut microbiome have been studied using human fecal specimens and multiple-stage complex gut models to determine the effects of dietary components on the gut microbial community and the effects of the gut microbiome on the overall well-being of the host. However, the entire functionality remains incompletely understood.

The review

This literature review explored current research findings on the effects of herbs and spices on gut microbes and the resulting health benefits.

Dietary modulation of the gut microbiota can improve overall health. Probiotics are dietary non-digestible carbohydrates that are not destroyed by the enzymes and digestive acids secreted by the upper digestive tract and enter the colon as fructans and galactans.

These metabolic byproducts are selectively utilized by beneficial bacteria which confer health benefits and improve the dysbiosis caused by illness, poor nutrition, aging, antibiotic use, and lifestyle alterations. Habitual consumption of probiotics can alter gut microbes by promoting specific bacterial populations.

Anaerobic gut bacteria ferment indigestible carbohydrates, which produce SCFAs (short-chain fatty acids). SCFAs impart numerous health benefits, such as – fat reduction, impeding type 2 diabetes mellitus (T2DM) progression, along with anticarcinogenic effects.

Another substance beneficial for health is prebiotics. Prebiotics are substrates selectively used by the host microbiome to confer health benefits. Prebiotics use several pathways leading to positive impacts on health. They promote polyphenol production; these modulate the gut microbiome.

Polyphenols are also found in herbs and spices; hence, these plant extracts may impose prebiotic effects. Polyphenols are phytochemicals; dietary polyphenols aid in maintaining gut homeostasis by selectively acting as prebiotics. They also show antipathogenic and antioxidant effects and play crucial roles in cell signaling, insulin sensitivity, and synthesizing inflammatory mediators.

About 90-95% of the dietary polyphenols reach the colon, are metabolized by gut microbes, and are transformed into metabolites that affect the bioavailability of polyphenols (and hence the health benefits).

Polyphenols can be structurally classified into flavonoids and non-flavonoids. Coumarin and tannins can also be included under dietary polyphenols. Flavonoids modulate the gut microbiome by transforming into absorbable metabolites from an unabsorbable parent. The metabolites, quantity of the consumed polyphenol, and action of gut microbes determine the health benefits. Tannins found in nuts and berries also confer health benefits by converting ellagitannins into urolithin metabolites. These two pathways cause homeostasis of the gut microbiome, prevent oxidative damage and inflammation, and confer an antimicrobial effect against invading pathogens.

However, there remain inconsistencies in herb and spice inventions. Such results can be attributed to the low bioavailability and the variable content of polyphenols in different plant derivatives. The polyphenol content also varies according to the harvesting techniques, shelf life, processing, and cooking methods.

Many studies have found that spices and herbs positively alter gut microbiota. Certain herbs also reduce the risk of cancer by acting as anti-inflammatory compounds. The anti-inflammatory effects are also pronounced in cardiovascular diseases and inflammatory bowel disease (IBD). Spices promote SCFA production, which has an anti-obesity effect. Researchers have the anti-obesity properties of ginger root. Moreover, ginger and turmeric benefit by increasing the number of beneficial gut microbes.

Conclusion

More studies are warranted to study the impacts of spices and herbs on the gut microbiome and their health benefits on the host before their inclusion into dietary guidelines.

Declaration of Competing Interest

The authors declared a conflict of interest, as one author works Pukka Herbs Ltd and another is in receipt of a PhD studentship funded by PUKKA Herbs Ltd.

Journal reference:

Written by

Nidhi Saha

I am a medical content writer and editor. My interests lie in public health awareness and medical communication. I have worked as a clinical dentist and as a consultant research writer in an Indian medical publishing house. It is my constant endeavor is to update knowledge on newer treatment modalities relating to various medical fields. I have also aided in proofreading and publication of manuscripts in accredited medical journals. I like to sketch, read and listen to music in my leisure time.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Saha, Nidhi. (2023, January 05). Current research on gut microbial modulation with culinary herbs and spices. News-Medical. Retrieved on January 05, 2023 from https://www.news-medical.net/news/20230105/Current-research-on-gut-microbial-modulation-with-culinary-herbs-and-spices.aspx.

  • MLA

    Saha, Nidhi. "Current research on gut microbial modulation with culinary herbs and spices". News-Medical. 05 January 2023. <https://www.news-medical.net/news/20230105/Current-research-on-gut-microbial-modulation-with-culinary-herbs-and-spices.aspx>.

  • Chicago

    Saha, Nidhi. "Current research on gut microbial modulation with culinary herbs and spices". News-Medical. https://www.news-medical.net/news/20230105/Current-research-on-gut-microbial-modulation-with-culinary-herbs-and-spices.aspx. (accessed January 05, 2023).

  • Harvard

    Saha, Nidhi. 2023. Current research on gut microbial modulation with culinary herbs and spices. News-Medical, viewed 05 January 2023, https://www.news-medical.net/news/20230105/Current-research-on-gut-microbial-modulation-with-culinary-herbs-and-spices.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like...
New technologies and recent advances in the study of T cells and T-cell epitope discovery in food allergy research

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

The WHO has established a traditional medicine chapter in its ICD-11.

Is traditional Indian medicine Ayurveda certified by the World Health Organization?

India seeks to include Ayurveda in the WHO's ICD-11 list to link traditional medicine to global norms.

What is the traditional Indian medical system called?

The WHO centre for traditional medicine will promote its safe and effective use to improve global health.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Establishing rules for the safe, fair, and effective use of traditional medicine